{
  "resource_uri": "http://www.courtlistener.com/api/rest/v3/opinions/200076/",
  "absolute_url": "/opinion/200076/medical-air-v-marwan-investment/",
  "cluster": "http://www.courtlistener.com/api/rest/v3/clusters/200076/",
  "author": null,
  "joined_by": [],
  "per_curiam": false,
  "date_created": "2011-02-07T04:43:37Z",
  "date_modified": "2016-02-28T05:02:08.120859Z",
  "type": "010combined",
  "sha1": "6df7824d1fa049ccb9ae8b49af6291754d7826c2",
  "download_url": "http://www.ca1.uscourts.gov/pdf.opinions/01-2348-01A.pdf",
  "local_path": "http://www.courtlistener.com/pdf/2002/08/14/Medical_Air_v._Marwan_Investment.pdf",
  "plain_text": "         United States Court of Appeals\n                    For the First Circuit\n                         ____________________\nNo. 01-2348\n                 MEDICAL AIR TECHNOLOGY CORPORATION,\n                         Plaintiff, Appellant,\n\n\n                                  v.\n\n     MARWAN INVESTMENT, INC.; MARWANI HOLDING COMPANY, N.V.;\n  MULTIFINANCE HOLDING CORPORATION; AND DR. K. PHILIP RAHBANY,\n                      Defendants, Appellees.\n                         ____________________\n\n          APPEAL FROM THE UNITED STATES DISTRICT COURT\n                FOR THE DISTRICT OF MASSACHUSETTS\n              [Hon. Joseph L. Tauro, U.S. District Judge]\n\n                         ____________________\n\n                                Before\n                      Torruella, Circuit Judge,\n                    Coffin, Senior Circuit Judge,\n                      and Lynch, Circuit Judge.\n\n\n                         ____________________\n\n\n     Louis N. Massery with whom Massery & Gillis, LLP, Albert L.\nFarrah Jr., and Corwin & Corwin, LLP were on brief for appellant.\n     James W. Prendergast with whom Michael G. Bongiorno, Peter J.\nKolovos, Barbara Van Gorder, and Hale and Dorr LLP were on brief\nfor appellees.\n                       ____________________\n\n                            August 14, 2002\n                         ____________________\n\f             LYNCH, Circuit Judge.      Medical Air Technology appeals a\n\njudgment rendered after a bench trial involving a closely held\n\ncorporation's     financial    travails     and   allegations     of   fiduciary\n\nviolations by one of its investors. The plaintiff Medical Air, the\n\nclosely held corporation, presents two claims of error: 1) that the\n\ndistrict court applied the wrong legal standard for a shareholder's\n\nfiduciary duty to a closely held corporation; and 2) that the\n\ndistrict court judge improperly found that Medical Air had waived\n\nits right to a jury trial against all of the defendants, and not\n\njust one of the defendants.             We affirm the district court's\njudgment,    because    the   defendants     were   not   in    breach   of   any\n\nfiduciary duties owed, and because there was no evidence that the\ndefendants' actions caused the harm that Medical Air suffered. The\nreasoning we use in affirming that judgment renders Medical Air's\n\nclaim, if any, to a jury trial irrelevant and disposes of all\nclaims in the case.\n                                       I.\n\n             Medical Air is a closely held corporation, incorporated\nin   1992,    which    sold   air    purification    equipment     to    medical\nfacilities.       In search of financing, Medical Air executed an\n\nagreement    in   January     1996   with   Multifinance       Holding   Company\n(\"MFH\"). MFH used two related holding companies, Marwan Investment\nand Marwani Holding Company, to structure the deal.                    Dr. Kalil\n\nPhilip Rahbany was the President of MFH and an agent of Marwan\nInvestment and Marwani Holding.\n\n\n\n                                       2\n\f            The agreement resulted in a total of $1.375 million in\n\nfunding for Medical Air: a $625,000 loan from Marwan Investment and\n\na $750,000 purchase of preferred stock by Marwani Holding. Medical\nAir signed an Investment and Stockholders Agreement, a Secured\n\nPromissory Note for the loan, and a Security Agreement.    It also\n\namended its Articles of Organization.   The Security Agreement was\nexecuted by Medical Air and Marwan Investment only and served to\n\nsecure the loan from Marwan Investment.       It contained a jury\n\nwaiver, which provided that:\n\n          Grantor [Medical Air] and Marwan hereby waive their\n          respective rights to a jury trial of any claim or cause\n          of action based upon or arising out of this Security\n          Agreement, the Investment and Stockholders Agreement or\n          any other agreement evidencing, securing, or otherwise\n          executed in connection with any Obligations.\n\nThe Security Agreement defines \"Obligations\" as:\n\n          any and all indebtedness, obligations, agreements and\n          liabilities of either Grantor to Marwan including,\n          without limitation, all indebtedness and obligations of\n          Grantor under the Investment and Stockholders Agreement,\n          the Notes executed pursuant thereto, and any other\n          indebtedness, obligations, agreements and liabilities of\n          Grantor to Marwan of every kind and description, direct\n          or indirect, absolute or contingent, due or to become\n          due, regardless of how they arose or were acquired, now\n          existing or hereafter arising.\n\nMFH and Medical Air also entered into a Consulting Agreement, under\n\nwhich MFH would provide specified consulting services to Medical\n\nAir for the fee of $4,000 a month.   Medical Air's President, Frank\n\nParadise, took the lead in negotiating the deal.   Medical Air was\n\nrepresented by counsel in the negotiations and the drafting of the\n\ninvestment agreements, as were the defendants.\n\n\n\n\n                                3\n\f             Within a few months, the relationship had soured.                      In\n\nMay, 1996, Medical Air failed to meet the minimum net worth and net\n\nworking    capital     requirements   to   which       it   had    agreed     in   the\nInvestment      and   Stockholders    Agreement.            The    Investment      and\n\nStockholders Agreement specified that if Medical Air defaulted on\n\nthese terms, then Marwan Investment could accelerate the loan,\nmaking     it    immediately    payable,       and    Marwani       Holding     could\n\nimmediately seek to redeem its stock.                If Medical Air failed to\n\nredeem the stock within six months, under the amended Articles of\n\nOrganization, its Board of Directors would double in size plus one,\n\nand Marwani Holding could appoint the new Board members.                    Thus, if\n\nthe stock was not redeemed after default, control of Medical Air\n\nwould shift to Marwani Holding.\n             Medical    Air    attempted       to    obtain       the    defendants'\n\npermission to issue additional stock in the hope that increased\n\nfunding would allow it to expand its production capacity to take\nadvantage of some inchoate sales opportunities.                     The defendants\n\nopposed this plan, fearing it would dilute their interest in the\n\ncompany.        Medical Air then presented the defendants with the\n\npossibility of a buy-out by an outside investor, but the defendants\n\nwere not interested.\n\n             Instead,    between   July    8    and    August      15,    1996,    the\n\ndefendants sent three separate notices of default to Medical Air\n\nand threatened litigation.         Efforts were made to restructure the\n\nbusiness, but these were unsuccessful.                In the August 15 notice,\n\nMarwan Investment exercised its right to demand acceleration of the\n\n\n                                      4\n\floan and, the following month, Marwani Holding requested that\n\nMedical Air redeem its stock.           In response, Medical Air began to\n\nlook for a new investor to buy out the defendants.                    During this\ntime, the defendants chose not to exercise their security rights\n\nagainst Medical Air, waiting to see if Medical Air could secure new\n\nfunding.    The parties agree that, by the fall of 1996, Medical Air\nwas out of money to fill orders and, to put it mildly, not doing\n\nwell.\n\n            A company called Nortek, Inc., expressed some interest in\n\na merger with Medical Air.          On November 8, 1996, Nortek and Medical\n\nAir signed a non-binding letter of intent, which proposed that\n\nMedical Air's shareholders would receive 500,000 shares of Nortek\n\ncommon stock, worth about seven to ten million dollars.                    Nortek\nreserved decision on a final purchase price for Medical Air until\n\nit saw whether Medical Air could meet its sales projections for the\n\nfourth     quarter    of   1996.       Medical    Air     quickly   scheduled    a\nshareholders' meeting for January 8, 1997.              Notices of the meeting\n\nand proxy were sent to Medical Air shareholders on December 19,\n\n1996.\n\n             On    November   19,    after    receiving    Nortek's    letter   of\n\nintent, Rahbany requested from Medical Air the due diligence\n\nmaterial provided to Nortek. Under the Investment and Shareholders\n\nAgreement, Marwani was entitled to receive any reasonably requested\n\ninformation       within   five    business   days.       Rahbany   says   he   was\n\nparticularly interested in any financial forecasts Medical Air had\n\nmade, because he wanted to assess whether Nortek's interest in\n\n\n                                         5\n\fMedical Air had a realistic basis. This concern was not unfounded;\n\nat trial, Medical Air's financial adviser testified that he warned\n\nMedical Air that, once Nortek had seen the due diligence materials,\nit would attempt to negotiate a lower purchase price.\n\n           Rahbany says he repeatedly requested the information over\n\ntwo months, but never received copies of what had been provided to\nNortek.    Medical Air, in turn, was \"reluctant to produce the\n\ndocuments because\" corporate officials felt that the defendants\n\nwere \"going fishing\" for evidence for their litigation in the\n\ndefault suit.    Medical Air also asked the defendants to identify\n\nthe specific items they wanted, and the reasons for each.               The\n\ndefendants refused, and reiterated their request for all the due\n\ndiligence documents.       At Medical Air's request, the defendants\nsigned a non-disclosure agreement, agreeing not to disclose any\n\ninformation about the proposed merger.\n\n           Medical Air says that it supplied Rahbany with the\ninformation that it judged to be necessary for Rahbany's review of\n\nthe   proposed   deal,   including   a   listing of   the   due   diligence\n\nmaterials (but not the materials themselves).          Medical Air's CEO\n\ntestified that he did not recall if he ever supplied the defendants\n\nwith the fourth quarter sales projections provided to Nortek.\n\nMedical Air's financial adviser who worked on the merger deal\n\ntestified that he never provided the defendants with the due\n\ndiligence materials.\n\n           On December 31, 1996, Medical Air sent a draft merger\n\nagreement and certain other draft documents to shareholders for\n\n\n                                     6\n\freview.   The defendants say that they were not able to assess the\n\ndeal in part because the terms, including the purchase price, had\n\nnot been finalized at that time.              According to the Medical Air\nattorney who worked on the deal, merger terms are never final until\n\nthe closing, and it is customary for shareholder votes to take\n\nplace before the merger documents are finalized.              The defendants\nalso say that they were unable to assess the viability of the deal\n\nbecause Medical Air's fourth quarter financial results were not yet\n\navailable.     The defendants had certain other problems with the\n\ndraft documents: the draft merger agreement stated that Marwan\n\nInvestment's loan would be repaid at the original interest rate,\n\nrather than the default interest rate triggered by Medical Air's\n\nMay 1996 default (a difference of less than $25,000); the shares\nthat Marwani Holding would receive in the proposed merger would not\n\nbe immediately saleable; and a portion of the shares would be\n\nsubject to loss if the warranties that Medical Air made in the\nmerger proved to be false.         Finally, the draft merger failed to\n\ngive Marwani Holding preferred shareholder rights, although Medical\n\nAir's amended Articles of Organization stated that any merger would\n\nmake \"appropriate provisions\" to provide the same privileges to\n\npreferred stockholders \"as nearly as may be, with respect to any\n\nshares of stock or securities\" received in a merger.\n\n             Five days before the scheduled vote, the parties met to\n\ndiscuss the proposed merger. At that meeting, the defendants asked\n\nfor five pieces of information: a statement from Nortek that due\n\ndiligence    was   satisfactory;    a       patent   assignment   release;   an\n\n\n                                        7\n\fexplanation of how the default loan interest rate would be dealt\n\nwith; a copy of the November financial statements; and a valuation\n\nof   the   company.   Medical    Air       says    it    provided     the   November\nfinancial statements, and a valuation of the defendants' stock\n\nunder the proposed merger plan (between $1.4 and $1.8 million) to\n\nthe defendants' counsel on the following day.                  Rahbany says he was\nnot given sufficient information to determine if that valuation was\n\na credible number, and says that he never received the November\n\nfinancial    statements.   At    that       time,       the    December     financial\n\nstatements were not yet ready.         Rahbany admitted at trial that he\n\nnever reviewed the public records of Nortek to try to assess the\n\nbasis for Nortek's interest in Medical Air.\n\n            Medical Air failed to meet its fourth quarter 1996\nprojections; it had projected sales of $750,000 for the quarter,\n\nbut realized only $236,000. Medical Air blames this failure on its\n\nproblems with the defendants, which it said were distracting its\nprincipal officers from business and demoralizing its sales force.\n\n            A day or two before the vote, Medical Air's president,\n\nFrank Paradise, was told by an associate of his that Marwani\n\nplanned to vote against the deal.                 Medical Air says that, as a\n\nresult of learning that Marwani intended to vote against the deal,\n\nit   reopened   negotiations    with       Nortek       on    the   day   before   the\n\nscheduled vote. The memory of Nortek's representative was that the\n\nnegotiations were reopened because Medical Air had failed to meet\n\nits fourth quarter projections.\n\n\n\n\n                                       8\n\f            At the January 8 vote, Marwani Holding voted against the\n\nmerger.     All other shareholders voted for the merger.                        Marwani\n\nHolding, holding almost 15% of the shares, was able to single-\nhandedly defeat the merger because Nortek, as part of the proposed\n\nmerger    agreement,    had   required        a    minimum     of   95%   stockholder\n\nagreement.       Still, the terms of the Investment and Stockholders\nAgreement appeared to allow Medical Air to proceed with a merger\n\nwithout the defendants' approval if the Medical Air Board of\n\nDirectors    certified    that      the       purchase     price    met    a    certain\n\n\"qualifying price\" defined in the Agreement.                   This was never done.1\n\n            Rahbany    testified     that         he   voted   against    the    merger\n\nbecause\n\n            I wanted at the same time to know how viable, to find the\n            basis, because I had a fiduciary responsibility to cast\n            a vote, and I had to have a reasonable basis for my\n            action. And when you don't know what you're doing, you\n            don't do anything.\n\nHe also testified that he voted against the deal because he did not\n\nthink that the deal was viable.                   He admitted that one of the\n\npurposes    of   his   vote   was   to    advance        the   purposes    of    Marwan\nInvestment, but stated that he \"had in mind the multiple entities\nthat [he] represented all the time and also the separateness all\n\nthe time.\"       After the shareholders' meeting, Marwani's attorney,\nwho tendered the proxy vote, told Medical Air's attorney that the\n\n\n\n     1\n          Rahbany testified that one of the reasons justifying his\nsuspicions of the deal was Medical Air's failure to certify the\npurchase price, although he did not voice that suspicion to Medical\nAir at the time.\n\n                                          9\n\fMedical Air principals would make a lot of money from the proposed\n\nmerger, while Rahbany was coming up short.\n\n          Medical Air and Nortek continued negotiations, and later\nin January 1997 Nortek signed a second letter of intent offering\n\n250,000 shares, while providing that the purchase price would not\n\nexceed $6.25 million. The defendants, for their part, continued to\nrequest more   information.       The    merger   ultimately   did   not   go\n\nthrough, and Medical Air blames this on the legal problems caused\n\nby the defendants.   Medical Air does not argue, however, that the\n\ndefendants violated any fiduciary duty with respect to their\n\nactions following the January 8 vote.\n\n                                   II.\n\n          In April 1997, Medical Air filed a diversity suit in the\nDistrict of Massachusetts, seeking a declaration that it was not in\n\ndefault to the defendants, an injunction against the sale of its\n\nassets, and damages for breach of contract, negligence and other\nclaims based on Marwani Holding's vote against the merger.                 On\n\nJanuary 26, 1998, the district court found that, as of May 1996,\n\nMedical Air was in default of its responsibilities under the\n\nInvestment   and   Stockholders    Agreement,      and   permitted   Marwan\n\nInvestment to sell Medical Air's assets.          Medical Air Tech. Corp.\n\nv. Marwan Inv., Inc., No. 97-10764-JLT (D. Mass. Jan. 26, 1998).\n\nMedical Air does not appeal this judgment.\n\n          The defendants did not immediately enforce their security\n\nrights against Medical Air; they say they were waiting to see if\n\nMedical Air could find a way to pull itself out of its financial\n\n\n                                   10\n\fhole.    In     August    1998,   Marwan   Investment   began   foreclosure\n\nproceedings against Medical Air.           At public auction in November\n\n1998, Marwan Investment bought all of Medical Air's remaining\nassets with a credit bid of $150,000.              Marwan says Medical Air\n\nstill owed a debt of $1,015,236 to Marwan on the 1996 loan.             The\n\ndefendants then moved for a dismissal of Medical Air's case,\narguing that their foreclosure purchase had included Medical Air's\n\nrights in this case.      The district court denied that motion on June\n\n22, 1999.     It also denied a motion by Medical Air's shareholders to\n\nintervene.\n\n            On August 10, 2000, the defendants filed a motion to\n\nstrike Medical Air's jury demand.          On January 12, 2001, the court\n\nheard argument on the jury waiver issue.             Medical Air's counsel\nargued that when Medical Air signed the Security Agreement it did\n\nnot understand that it was waiving jury trial, but he conceded that\n\nthe Security Agreement effected a valid waiver of the right to jury\nwith respect to Marwan Investment.           Nonetheless, he argued that\n\nMedical Air had not waived jury trial for any of the other\n\ndefendants.     The district court judge expressed concern about the\n\nfeasibility of having a bench trial for one defendant and a\n\nsimultaneous jury trial for the others. The defendants argued that\n\nthe plaintiff had presented a claim under Mass. Gen. L. ch. 93A,\n\nwhich could not be considered by a jury, and so the judge \"would\n\nhave to make findings that would be the mirror findings of\" the\n\njury findings.        The court did not conduct an evidentiary hearing\n\n(none   had    been    requested),   but    both   parties   had   submitted\n\n\n                                      11\n\faffidavits. The court allowed the motion to strike the jury demand\n\nwithout issuing a written order explaining the basis for its\n\ndecision.   However, it appears that the trial judge believed that,\nin a case arising out of a single transaction and presenting claims\n\nagainst multiple defendants, a waiver against one was a waiver\n\nagainst all.2\n            After the court ruled on the defendants' summary judgment\n\nmotion, three of Medical Air's claims remained for trial: 1) breach\n\nof contract and of the implied covenant of good faith and fair\n\ndealing as to MFH and Marwani Holding; 2) breach of fiduciary duty\n\nas   to   Marwani   Holding;   and    3)   tortious   interference   with\n\ncontractual and business relations as to all the defendants.\n\n            At the conclusion of the four day bench trial, the\ndistrict court ruled for the defendants on each of Medical Air's\n\nremaining claims and entered judgment in the amount of $1,015,236,\n\nplus post-trial interest, for Marwan Investment on its counterclaim\n\n     2\n          The court initially noted, \"If I understand correctly,\nregardless of whether you think -- you talk in terms of integrated\ndocuments or anything else, it is very, very clear that the\nplaintiff waived jury; is that right?\"       Medical Air's counsel\nresponded by arguing that the only waiver was in the Security\nAgreement, and it applied only to Marwan Investment. The judge\nthen said:\n     But you did waive.    With respect to this case, you waived\n     jury.\n     . . .\n     Do you know of any precedent where you can waive with respect\n     to one defendant and not with respect to another?       I have\n     never tried a case like that. I would not know how to preside.\n     . . . I am just talking about within the cast, the traditional\n     cast, of a transaction, one plaintiff, four people, some\n     actual signatory, some by inference, perhaps, but the\n     plaintiff says, I waive jury.        Doesn't that count for\n     everything?\n\n                                     12\n\fbased on Medical Air's default of the Investment Agreement.              It\n\nalso ruled    for   the   plaintiffs   on   the   defendants'   good   faith\n\ncounterclaim.    Med. Air Tech. Corp. v. Marwan Inv., Inc., No. 97-\n\n10764-JLT (D. Mass. Aug. 21, 2001).\n\n                                  III.\n\n          On appeal to this court, Medical Air primarily challenges\n\ntwo of the district court's rulings: its order dismissing the jury\n\ndemand, and its ruling that Marwani Holding was not in breach of\n\nits fiduciary duty as a stockholder.          The defendants defend the\n\ncourt's rulings on the grounds given by the district court.             They\nalso argue, in the alternative, that the district court's judgment\n\nshould be upheld because Marwan Investment became the assignee of\nMedical Air's right to pursue this case when it bought all Medical\nAir's assets in foreclosure.\n\nA. Jury Trial\n\n          Medical Air argues that the trial judge erred in granting\nthe defendants' motion to strike Medical Air's jury demand as to\n\nits claims against Dr. Rahbany, MFH, and Marwani Holding, because\nonly Marwan Investment was party to the Security Agreement which\ncontained the jury waiver.\n\n          The confusion on this issue evident in the record leads\nus to review basic principles.          There is a presumption against\ndenying a jury trial based on waiver, and waivers must be strictly\n\nconstrued.3     Aetna Ins. Co. v. Kennedy ex rel. Bogash, 301 U.S.\n\n\n     3\n          The circuits are currently split on the question of which\nparty bears the burden of proof as to whether a contractual jury\n\n                                   13\n\f389, 393 (1937) (\"[A]s the right of jury trial is fundamental,\n\ncourts indulge every reasonable presumption against waiver.\");\n\nParacor Fin., Inc. v. Gen. Elec. Capital Corp., 96 F.3d 1151, 1166\nn.21 (9th Cir. 1996).                In a diversity jurisdiction suit, the\n\nenforcement of a jury waiver is a question of federal, not state,\n\nlaw.    See Simler v. Conner, 372 U.S. 221, 222 (1963).\n\n               In general, a contractual waiver binds only the parties\n\nwho sign the contract.            See EEOC v. Waffle House, Inc., 122 S. Ct.\n\n754, 764 (2002) (\"It goes without saying that a contract cannot\n\nbind a nonparty.\").          In Waffle House, the Supreme Court held that\n\nthe    EEOC    was    not    bound    by   an   employer-employee      contractual\n\narbitration agreement, reasoning that \"[a]bsent some ambiguity in\n\nthe agreement, . . . it is the language of the contract that\ndefines       the    scope   of   disputes      subject    to    arbitration,\"   and\n\ntherefore even the federal policy favoring arbitration does not\n\n\"authorize[] a court to compel arbitration . . . by any parties .\n. . that are not already covered in the agreement.\"                   Id. at 762.\n\n               There are some exceptions to this rule.               For instance,\n\nsome courts have applied a theory of equitable estoppel for suits\n\nagainst       non-signatories        arising    out   of   the    contract   itself,\n\n\ntrial waiver was knowing and voluntary. See Pierce v. Atchison\nTopeka & Santa Fe Ry. Co., 110 F.3d 431, 435 n.4 (7th Cir. 1997)\n(collecting cases); Hulsey v. West, 966 F.2d 579, 581 (10th Cir.\n1992). We have not yet ruled on this point, although a district\ncourt within this circuit has held that the party seeking to\nenforce the waiver bears the burden. See Luis Acosta, Inc. v.\nCitibank, N.A., 920 F. Supp. 15, 18 (D.P.R. 1996).         In the\nanalogous situation of a release of claims against an employer, we\nhave held that the party seeking to enforce the release bears the\nburden of proof. See Melanson v. Browning-Ferris Indus., 281 F.3d\n272, 276 (1st Cir. 2002). We need not resolve the issue here.\n\n                                           14\n\freasoning that the party seeking the benefit of a contract could\n\nnot refuse to be bound by a clause contained within it.                    E.g.,\n\nGrigson v. Creative Artists Agency, L.L.C., 210 F.3d 524, 527-31\n(5th Cir.), cert. denied, 531 U.S. 1013 (2000); MS Dealer Serv.\n\nCorp. v. Franklin, 177 F.3d 942, 947-48 (11th Cir. 1999); Hughes\n\nMasonry Co. v. Greater Clark County Sch. Bldg. Corp., 659 F.2d 836,\n841 & n.9 (7th Cir. 1981).\n\n               In general, though, we look to the plain language of the\n\ncontract's jury waiver to determine whether it unambiguously covers\n\nthe claims asserted.         In cases where the contractual language is\n\nambiguous, simultaneously executed documents may be relevant as a\n\nmatter of contractual interpretation. In Massachusetts, \"if the\n\nparties execute two or more documents, with a manifested intent\nthat the documents together express their entire agreement, a court\n\nreads the documents together, rather than construing each as if it\n\nstood alone.\"       Donoghue v. IBC USA (Publ'ns), Inc., 70 F.3d 206,\n\n212 (1st Cir. 1995); see also FDIC v. Singh, 977 F.2d 18, 21-22\n\n(1st Cir. 1992); Chase Comm. Corp. v. Owen, 32 Mass. App. Ct. 248,\n\n588 N.E.2d 705, 707 (1992); cf. Paracor Fin., 96 F.3d at 1165\n\n(holding that this is \"a principle of interpretation [which] does\n\nnot mean that contemporaneously executed documents somehow become\n\na     single    unified    contract     binding   all   signatories   to     all\n\nprovisions\").\n\n               Even once it is determined that a contractual jury waiver\n\nclause does encompass the asserted claims, courts will not enforce\n\nthe    jury     waiver    unless   it   was   entered   into   knowingly     and\n\n\n                                         15\n\fvoluntarily.      See Seaboard Lumber Co. v. United States, 903 F.2d\n\n1560, 1563 (Fed. Cir. 1990); Telum, Inc. v. E.F. Hutton Credit\n\nCorp., 859 F.2d 835, 837 (10th Cir. 1988) (jury waiver may not be\nfraudulently induced); K.M.C. Co. v. Irving Tr. Co., 757 F.2d 752,\n\n755-56 (6th Cir. 1985).      In cases such as this, where the jury\n\nwaiver was part of a separate contract, signed only by certain\nparties to the larger transaction, non-signatory parties seeking\n\nenforcement of the waiver may have a more difficult task in showing\n\nthat the waiver was voluntary and knowing.        This is, however, a\n\nfact-based     inquiry.4   See   Smart   v.   Gillette   Co.   Long-Term\n\nDisability Plan, 70 F.3d 173, 182 (1st Cir. 1995).\n\n          Medical Air has conceded that it made a valid jury waiver\n\nwith regards to all claims against Marwan Investment.          The record\nis sparse as to the basis for the trial court's ruling.        We do not,\n\nthough, need to decide the issue.      As we hold below, no reasonable\n\njury could find liability for breach of fiduciary duty against\nMarwani Holding nor a causal link between Marwani Holding's vote at\n\nthe January 8 board meeting and the failure of the proposed merger\n\nwith Nortek.\n\n\n\n     4\n          In analogous situations we have looked to the \"totality\nof the circumstances,\" including factors such as the waiving\nparty's education and business experience, the respective roles of\nthe parties in determining the terms of the waiver, the clarity of\nthe agreement, the amount of time the waiving party had to consider\nthe waiver, whether the waiving party was represented by counsel,\nand the consideration offered for the waiver, to determine if the\nwaiver was knowing and voluntary. Melanson, 281 F.3d at 276 & n.4\n(waiver of Title VII rights through release of claims against\nemployer); Smart v. Gillette Co. Long-Term Disability Plan, 70 F.3d\n173, 181-82 (1st Cir. 1995) (waiver of ERISA pension benefits).\n\n                                  16\n\f            Because the core ruling is correct and none of Medical\n\nAir's claims could survive a motion for judgment as a matter of\n\nlaw, the jury waiver question is no longer viable.                 See Segrets\n\nv. Gillman Knitwear Co., 207 F.3d 56, 64 (1st Cir. 2000); In re N-\n\n500L Cases, 691 F.3d 15, 25 (1st Cir. 1982).            See generally 9 C.\n\nWright & A. Miller, Federal Practice and Procedure ยง 2322 n.6 (2d\ned. 1995 & Supp. 2002) (collecting cases).\n\nB.   Fiduciary Duty\n\n1.   Alleged Breach of Duty\n\n            Under   Massachusetts     law,    shareholders     in    a   close\n\ncorporation   owe   a   fiduciary    duty    of   \"utmost   good    faith   and\n\nloyalty.\"   Zimmerman v. Bogoff, 402 Mass. 650, 524 N.E.2d 849, 853\n\n(1988) (quoting Donahue v. Rodd Electrotype Co. of New England, 367\nMass. 578, 328 N.E.2d 505, 515 (1975)) (internal quotation marks\n\nomitted).   This is a higher standard than a simple \"good faith and\n\ninherent fairness\" standard.        Donahue, 328 N.E.2d at 515-16.          The\nMassachusetts Supreme Judicial Court (SJC) has articulated a two-\n\npart test for determining if this fiduciary duty has been violated.\nFirst, the defendant must show a legitimate business purpose for\n\nits action that allegedly is a breach.        If the defendant makes such\n\na showing, the burden shifts to the plaintiff to show that \"the\n\nproffered legitimate objective could have been achieved through a\n\nless harmful, reasonably practicable, alternative mode of action.\"\n\nZimmerman, 524 N.E.2d at 853.          Then the court \"must weigh the\n\nlegitimate business purpose, if any, against the practicability of\n\na less harmful alternative.\"        Wilkes v. Springside Nursing Home,\n\n\n                                     17\n\f370 Mass. 842, 353 N.E.2d 657, 663 (1976).                In applying this test,\n\ncourts must be sure not to \"unduly hamper . . . effectiveness in\n\nmanaging the corporation in the best interests of all concerned.\"\nId.   Moreover, \"mere errors of judgment\" do not constitute a\n\nfiduciary breach. Spiegel v. Beacon Participations, 297 Mass. 398,\n\n8 N.E.2d 895, 904 (1937).\n            Donahue     itself      involved        an    attempt        by     majority\n\nstockholders to freeze out minority shareholders.                       328 N.E.2d at\n\n509-11.     See generally Peter M. Rosenblum, Corporate Fiduciary\n\nDuties in Massachusetts and Delaware, in How to Incorporate and\n\nCounsel a Business (Massachusetts Continuing Legal Education, Inc.\n\n1999).     By contrast, this case involves actions by 15% minority\n\nshareholders.         Massachusetts       law       is    clear       that      minority\nshareholders     in     close       corporations          also     have       fiduciary\n\nresponsibilities.      See A.W. Chesterton Co. v. Chesterton, 128 F.3d\n\n1, 5-6 (1st Cir. 1997); Zimmerman, 524 N.E.2d at 853; Donahue, 328\nN.E.2d at 517; Smith v. Atl. Props., Inc., 12 Mass. App. Ct. 201,\n\n422 N.E.2d 798, 801-02 (1981).               Chesterton and Smith involved\n\nsituations in which unilateral action by minority shareholders\n\nwould result in dire tax consequences to the majority shareholders.\n\nSee A.W. Chesterton Co., 128 F.3d at 3; Smith, 422 N.E.2d at 800.\n\nFurther,    because    the    financial      obligations         were    owed    to   the\n\ngovernment,    there    was    no   market        mechanism      to     determine     the\n\nconsequences    of     the    action.        In    that    sense,       the     minority\n\nshareholders had effective control over one aspect of corporate\n\nfinances.     Here, by contrast, the defendants did not inherently\n\n\n                                        18\n\fhave effective control.    Their 15% was needed only because the\n\noutside purchasers set as a condition of sale that 95% of the\n\nshareholders approve the merger.   The Donahue rule itself involves\na balancing of legitimate interests, and the scope of the duties\n\nowed may depend, in part, on context.    See Zimmerman, 524 N.E.2d at\n\n853 (\"[T]he Donahue remedy is not intended to place a strait jacket\non legitimate corporate activity.\")\n\n           The district court here found that \"[l]acking th[e]\n\ninformation   [concerning the basis for the merger, the final terms\n\nof the merger, or the price that would be paid], Marwani certainly\n\nhad a legitimate business reason for voting against the merger\"\n\nand, further, that Medical Air's refusal to provide the requested\n\ninformation \"left Marwani with no choice but to vote against\nmerger.\"   The district court then found that the only alternative\n\nadvanced by Medical Air was for Marwani simply to vote for the\n\nNortek merger, an alternative that totally failed to address the\nproblems with the deal itself.        This showing does not meet the\n\nplaintiff's burden.\n\n           Medical Air argues that the district judge improperly\n\nconstrued the Massachusetts law governing fiduciary duty in closely\n\nheld relationships by holding that Marwani Holding's own business\n\ninterests could be a proper motivating factor for the vote.        It\n\nargues that Marwani's vote against the merger was not motivated by\n\nlegitimate business interests, saying that the vote was really\n\nmotivated by the defendants' own self-interest -- specifically,\n\nthat Marwani wanted more of the proceeds of the merger to go to\n\n\n                                 19\n\fMarwan, rather than the Medical Air principals.                     It says that\n\nMarwani's vote against the merger was intended to pave the way for\n\nMarwan's foreclosure of Medical Air's assets, given that Medical\nAir's financial situation was so desperate in January 1997 that the\n\nmerger was the only way to salvage the business.                     Medical Air\n\nrelies heavily on Rahbany's testimony admitting that he did take\nMarwan   Investment's       and    Marwani       Holding's    interests        into\n\nconsideration in his decision.               It also relies on the statement\n\nthat Marwani Holding's counsel allegedly made after the January 8\n\nvote, complaining that Rahbany would not make enough money out of\n\nthe proposed deal.\n\n            Medical Air mischaracterizes the trial court's holding.\n\nThe trial court held that Marwani Holding had a legitimate purpose\nin voting against the merger when it had not been provided material\n\ninformation about the merger and perceived a risk that the proposed\n\nmerger was made of gossamer.             That legitimate purpose is not\nnegated if Marwani Holding's vote also coincided with its self-\n\ninterest.\n\n            We    reject   Medical      Air's    argument    that    a   minority\n\nshareholder      may   never,   under   the     Donahue rule,   take     its   own\n\ninterest into account in deciding its vote.              Such an argument is\n\nboth unrealistic and too biased.                 The SJC has observed that\n\nstockholders in a close corporation \"may not act out of avarice,\n\nexpediency, or self-interest in derogation of their duty of loyalty\n\nto the other stockholders and to the corporation.\"                       Blank v.\n\nChelmsford OB/Gyn, P.C., 420 Mass. 404, 649 N.E.2d 1102, 1105\n\n\n                                        20\n\f(1995) (emphasis added); see also Donahue, 328 N.E.2d at 515 (using\n\nsame language). But self-interest may be a proper motive for a\n\nstockholder's actions, so long as that interest does not result in\nacts in derogation of the stockholder's fiduciary duty.          The SJC\n\nhas held that majority stockholders \"have certain rights to what\n\nhas been termed 'selfish ownership' in the corporation which should\nbe balanced against the concept of their fiduciary obligation.\"\n\nWilkes, 353 N.E.2d at 663.      We think that principle extends, at\n\nleast in part, to minority stockholders, although their interests\n\nare somewhat different in character.      See A.W. Chesterton Co., 128\n\nF.3d at 7 (noting that minority stockholders may control some\n\naspects of a corporation but not others). Admittedly, there may be\n\ntensions between the two types of interests -- loyalty to the\ncorporation and selfish ownership.        Difficult cases will arise\n\nwhere the dividing line is not clear.       This is not one of those\n\ncases.\n          The district court correctly found that Marwani Holding\n\nhad shown a legitimate business rationale for the vote against the\n\nmerger.    To   begin   with,   Marwani   Holding   did   lack   material\n\ninformation about the proposed merger and Medical Air had failed to\n\nprovide Marwani Holding with the requested due diligence materials.\n\nMarwani Holding also had a suspicion, reasonable in context, that\n\nthe deal was based on unrealistic assumptions that would ultimately\n\ndoom it, and that it served only as a distraction from the real\n\nproblems facing Medical Air.       This suspicion was well-founded;\n\nMedical Air's CEO admitted at trial that the fourth quarter sales\n\n\n                                   21\n\festimates for 1996 provided to Nortek were above what Medical Air\n\nhad ever accomplished before and far exceeded its actual fourth\n\nquarter sales results.   These reasons more than suffice to show a\nlegitimate business reason for Marwani's vote.\n\n          Upon this showing, the burden shifted to Medical Air to\n\nshow that there was \"a less harmful, reasonably practicable,\nalternative mode of action\" other than the vote against the merger.\n\nMedical Air has not made any such showing.       The district court\n\nfound that Medical Air's proposed alternative -- that Marwani could\n\nhave simply voted for the merger -- is not a reasonable and\n\npracticable alternative, given Marwani's legitimate concerns about\n\nwhat form the deal would ultimately take, or whether the whole deal\n\nwas simply a chimera.    Its finding was compelled by the evidence.\n2.   Causation\n\n           The defendants argue in the alternative that, even if\n\nMarwani Holding had violated a fiduciary duty in voting against the\nmerger, it was not the cause of the merger's failure.     We agree.\n\nNortek's CEO testified at trial (through deposition) that after\n\nNortek saw the fourth quarter sales results, it decided that it\n\nshould pay less than was offered in the original letter of intent\n\nand reopened negotiations with Medical Air. The renegotiated offer\n\nfrom Nortek, as expressed in the second letter of intent, provided\n\nonly half what was offered in the deal before the Board at the\n\nJanuary 8 vote.   It is clear that Nortek was not willing to go\n\nthrough with the terms of the earlier proposed merger put before\n\nthe Board that Marwani voted against.   Even if Marwani Holding had\n\n\n                                 22\n\fvoted for the proposed merger, it would have made no difference.\n\nMedical Air still would have been in the same position as it was\n\nafter the January 8 vote, negotiating new terms with Nortek.        No\nreasonable jury could find that Marwani Holding's vote was the\n\nproximate cause of the demise of the proposed Nortek merger.\n\nC. Other Claims\n\n           The plaintiff's other claims are similarly lacking in\n\nmerit.    The remaining questions decided by the district court in\n\nthe bench trial were: a claim against MFH for breach of the\n\nconsulting agreement; a breach of the implied covenant of good\n\nfaith and fair dealing against Marwani Holding based on its vote\n\nagainst   the   Nortek   merger;   and   tortious   interference   with\n\ncontractual relations against Rahbany, MFH, and Marwani Holding for\n\ntheir actions with regard to the Nortek merger.5       The latter two\n\nclaims must fail, for the same reasons that the fiduciary duty\nclaim against Marwan Holding fails.      Neither Rahbany nor MFH took\nany actions with regards to the Nortek deal that were separate from\n\nthe actions taken by Marwan Holding, discussed above.      Medical Air\nhas not presented any evidence to indicate that these actions,\nrather than Medical Air's inability to meet fourth quarter sales\n\nprojections, caused the proposed merger before the Board on January\n8 to fail.   Without causation, there can be no claim for tortious\ninterference, see United Truck Leasing Corp. v. Geltman, 406 Mass.\n\n\n     5\n          Medical Air did not appeal the merits of the district\ncourt's rulings on these claims. We consider the question only for\nthe purpose of Medical Air's appeal of the denial of a jury trial\non all of its claims against MFH, Rahbany and Marwani Holding.\n\n                                   23\n\f811, 551 N.E.2d 20, 21 (1990), or for a breach of the implied\n\ncovenant of good faith and fair dealing, see Druker v. Roland Wm.\n\nJutras Assocs., 370 Mass. 383, 348 N.E.2d 763, 765 (1976) (\"'[I]n\nevery contract there is an implied covenant [of good faith and fair\n\ndealing] that neither party shall do anything which will have the\n\neffect of destroying or injuring the right of the other party to\nreceive the fruits of the contract . . . .'\") (quoting Uproar Co.\n\nv.   Nat'l   Broad.   Co.,   81   F.2d     373,   377   (1st    Cir.   1936));\n\nMacGillivary v. W. Dana Bartlett Ins. Agency of Lexington, Inc., 14\n\nMass. App. Ct. 52, 436 N.E.2d 964, 967 (1982).\n\n             That leaves only Medical Air's claim that MFH violated\n\nits contractual obligations under the consulting agreement.                 The\n\ndistrict court outlined the alleged claim well in its opinion. The\n\nconsulting    agreement    required    MFH   to   provide      \"financial   and\nstrategic corporate planning services\" to Medical Air \"including,\nby way of example: (i) assisting [Medical Air] in attracting a new\n\nsenior leader; (ii) evaluating and helping source transactions such\nas acquisitions, joint ventures and public offerings; and (iii)\nassisting [Medical Air] in developing financial and operating\n\nreporting systems.\"       Medical Air's CEO, Stephen Hague, testified\n\nthat MFH did nothing to help attract a new lender or to develop\n\nfinancial and operating reporting systems.              However, Hague also\n\ntestified that he met on a monthly basis for a few hours with the\nconsultant provided by MFH, as well as speaking with him on the\nphone for a few hours each month.             During these meetings, the\n\n\n                                      24\n\fconsultant reviewed the operation of the company and proposals for\n\nthe company. According to Hague, the consultant encouraged Medical\n\nAir to expand its sales force rapidly; assisted in putting together\nan expansion plan; recommended and outlined the creation of a\n\nbusiness advisory board; and investigated at least one possible\n\nacquisition. The consultant also occasionally interviewed or spoke\n\nwith sales representatives.    In addition, Medical Air did effect\n\nchanges in its accounting procedures during this time period; the\n\nconsultant was copied on the relevant documents, but the record is\n\nnot clear as to what his level of participation was.\n\n          In August 1996, the consultant who had been working with\n\nMedical Air ceased to work for MFH.      In September, Medical Air\n\nstopped paying the $4,000 per month consultancy fee.    In October\n\n1996, Medical Air met with a new individual that MFH had appointed\n\nto replace the previous consultant, but that was the last service\n\nprovided under the consultancy agreement.    At this point, Medical\n\nAir was already in default of its obligations under the Investment\n\nand Stockholders Agreement.6\n          Based on the information provided by Medical Air's CEO,\n\nwe doubt that Medical Air has presented enough evidence on this\nclaim for it to go to a jury.        It is undisputed that the MFH\nconsultant worked with Medical Air throughout the relevant time\n\nperiod and provided input on the business's development.    As the\n\n\n     6\n          Medical Air did not argue that MFH's breach was based on\nthe failure to provide ongoing consultancy services after September\n1996.\n\n                                25\n\fdistrict court noted, the fact that the MFH consultant did not\n\nachieve all of the goals laid out \"by way of example\" in the\n\nconsulting agreement did not constitute breach, given how quickly\nthe entire relationship disintegrated and the agreement's lack of\n\nany time frame for achieving these goals.\n\n            Regardless of the strength of the claim, however, the\n\nclaim is no longer Medical Air's to make.                   Marwan Investment\n\npurchased all the assets of Medical Air at the foreclosure sale in\n\nNovember 1998.        The description of assets included           \"all rights,\n\nclaims,    counterclaims,      crossclaims,        demands,    recoveries     and\ndefenses in connection with or asserted or which may be asserted by\n\nMedical    Air   in    that   certain    litigation     styled     Medical    Air\n\nTechnology Corporation v. Marwan Investment . . . pending in the\nUnited States District Court for the District of Massachusetts.\"\n\nUnder    Massachusetts     law,   claims     for   breach     of   contract   are\ngenerally assignable.7        Raymer v. Bay State Nat'l Bank, 384 Mass.\n\n310, 424 N.E.2d 515, 518 (1981); see also SAPC, Inc. v. Lotus Dev.\n\nCorp., 921 F.2d 360 (1st Cir. 1990).           Although there may be cases\n\nin which public policy concerns merit the creation of an exception\nto that rule when the claim has been involuntarily assigned through\n\na foreclosure sale, this is not such a case.                  If the claim for\n\nbreach of the consulting agreement constituted a defense to the\n\ndefendants' claim of default, or if it would have saved Medical Air\n\n     7\n          The defendants have argued that all of Medical Air's\nclaims are assignable, whether or not they sound in contract. We\nneed not decide this point, as we have disposed of Medical Air's\nother claims on other grounds.\n\n                                        26\n\fas an ongoing concern, than Medical Air should have raised this as\n\na defense to the defendants' summary judgment motion on the default\n\nclaim.     Medical   Air   did   not    do   so,   nor   did   it   raise   any\ncontemporaneous objection to the inclusion of its rights in this\n\nmatter in the assets foreclosure sale.\n\nConclusion\n\n           The district court's decision is affirmed.           No costs are\n\nawarded.\n\n\n\n\n                                       27\n\f",
  "html": "<p class=\"case_cite\">303 F.3d 11</p>\n    <p class=\"parties\">MEDICAL AIR TECHNOLOGY CORPORATION, Plaintiff, Appellant,<br>v.<br>MARWAN INVESTMENT, INC.; Marwani Holding Company, N.V.; Multifinance Holding Corporation; and Dr. K. Philip Rahbany, Defendants, Appellees.</p>\n    <p class=\"docket\">No. 01-2348.</p>\n    <p class=\"court\">United States Court of Appeals, First Circuit.</p>\n    <p class=\"date\">Heard May 6, 2002.</p>\n    <p class=\"date\">Decided August 14, 2002.</p>\n    <div class=\"prelims\">\n      <p class=\"indent\">Louis N. Massery with whom Massery &amp; Gillis, LLP, Albert L. Farrah Jr., and Corwin &amp; Corwin, LLP were on brief for appellant.</p>\n      <p class=\"indent\">James W. Prendergast with whom Michael G. Bongiorno, Peter J. Kolovos, Barbara Van Gorder, and Hale and Dorr LLP were on brief for appellees.</p>\n      <p class=\"indent\">Before TORRUELLA, Circuit Judge, COFFIN, Senior Circuit Judge, and LYNCH, Circuit Judge.</p>\n      <p class=\"indent\">LYNCH, Circuit Judge.</p>\n    </div>\n    <div class=\"num\" id=\"p1\">\n      <span class=\"num\">1</span>\n      <p class=\"indent\">Medical Air Technology appeals a judgment rendered after a bench trial involving a closely held corporation's financial travails and allegations of fiduciary violations by one of its investors. The plaintiff Medical Air, the closely held corporation, presents two claims of error: 1) that the district court applied the wrong legal standard for a shareholder's fiduciary duty to a closely held corporation; and 2) that the district court judge improperly found that Medical Air had waived its right to a jury trial against all of the defendants, and not just one of the defendants. We affirm the district court's judgment, because the defendants were not in breach of any fiduciary duties owed, and because there was no evidence that the defendants' actions caused the harm that Medical Air suffered. The reasoning we use in affirming that judgment renders Medical Air's claim, if any, to a jury trial irrelevant and disposes of all claims in the case.</p>\n    </div>\n    <p class=\"center\">\n      <i>I.</i>\n    </p>\n    <div class=\"num\" id=\"p2\">\n      <span class=\"num\">2</span>\n      <p class=\"indent\">Medical Air is a closely held corporation, incorporated in 1992, which sold air purification equipment to medical facilities. In search of financing, Medical Air executed an agreement in January 1996 with Multifinance Holding Company (\"MFH\"). MFH used two related holding companies, Marwan Investment and Marwani Holding Company, to structure the deal. Dr. Kalil Philip Rahbany was the President of MFH and an agent of Marwan Investment and Marwani Holding.</p>\n    </div>\n    <div class=\"num\" id=\"p3\">\n      <span class=\"num\">3</span>\n      <p class=\"indent\">The agreement resulted in a total of $1.375 million in funding for Medical Air: a $625,000 loan from Marwan Investment and a $750,000 purchase of preferred stock by Marwani Holding. Medical Air signed an Investment and Stockholders Agreement, a Secured Promissory Note for the loan, and a Security Agreement. It also amended its Articles of Organization. The Security Agreement was executed by Medical Air and Marwan Investment only and served to secure the loan from Marwan Investment. It contained a jury waiver, which provided that:</p>\n    </div>\n    <div class=\"num\" id=\"p4\">\n      <span class=\"num\">4</span>\n      <p class=\"indent\">Grantor [Medical Air] and Marwan hereby waive their respective rights to a jury trial of any claim or cause of action based upon or arising out of this Security Agreement, the Investment and Stockholders Agreement or any other agreement evidencing, securing, or otherwise executed in connection with any Obligations.</p>\n    </div>\n    <div class=\"num\" id=\"p5\">\n      <span class=\"num\">5</span>\n      <p class=\"indent\">The Security Agreement defines \"Obligations\" as:</p>\n    </div>\n    <div class=\"num\" id=\"p6\">\n      <span class=\"num\">6</span>\n      <p class=\"indent\">any and all indebtedness, obligations, agreements and liabilities of either Grantor to Marwan including, without limitation, all indebtedness and obligations of Grantor under the Investment and Stockholders Agreement, the Notes executed pursuant thereto, and any other indebtedness, obligations, agreements and liabilities of Grantor to Marwan of every kind and description, direct or indirect, absolute or contingent, due or to become due, regardless of how they arose or were acquired, now existing or hereafter arising.</p>\n    </div>\n    <div class=\"num\" id=\"p7\">\n      <span class=\"num\">7</span>\n      <p class=\"indent\">MFH and Medical Air also entered into a Consulting Agreement, under which MFH would provide specified consulting services to Medical Air for the fee of $4,000 a month. Medical Air's President, Frank Paradise, took the lead in negotiating the deal. Medical Air was represented by counsel in the negotiations and the drafting of the investment agreements, as were the defendants.</p>\n    </div>\n    <div class=\"num\" id=\"p8\">\n      <span class=\"num\">8</span>\n      <p class=\"indent\">Within a few months, the relationship had soured. In May, 1996, Medical Air failed to meet the minimum net worth and net working capital requirements to which it had agreed in the Investment and Stockholders Agreement. The Investment and Stockholders Agreement specified that if Medical Air defaulted on these terms, then Marwan Investment could accelerate the loan, making it immediately payable, and Marwani Holding could immediately seek to redeem its stock. If Medical Air failed to redeem the stock within six months, under the amended Articles of Organization, its Board of Directors would double in size plus one, and Marwani Holding could appoint the new Board members. Thus, if the stock was not redeemed after default, control of Medical Air would shift to Marwani Holding.</p>\n    </div>\n    <div class=\"num\" id=\"p9\">\n      <span class=\"num\">9</span>\n      <p class=\"indent\">Medical Air attempted to obtain the defendants' permission to issue additional stock in the hope that increased funding would allow it to expand its production capacity to take advantage of some inchoate sales opportunities. The defendants opposed this plan, fearing it would dilute their interest in the company. Medical Air then presented the defendants with the possibility of a buy-out by an outside investor, but the defendants were not interested.</p>\n    </div>\n    <div class=\"num\" id=\"p10\">\n      <span class=\"num\">10</span>\n      <p class=\"indent\">Instead, between July 8 and August 15, 1996, the defendants sent three separate notices of default to Medical Air and threatened litigation. Efforts were made to restructure the business, but these were unsuccessful. In the August 15 notice, Marwan Investment exercised its right to demand acceleration of the loan and, the following month, Marwani Holding requested that Medical Air redeem its stock. In response, Medical Air began to look for a new investor to buy out the defendants. During this time, the defendants chose not to exercise their security rights against Medical Air, waiting to see if Medical Air could secure new funding. The parties agree that, by the fall of 1996, Medical Air was out of money to fill orders and, to put it mildly, not doing well.</p>\n    </div>\n    <div class=\"num\" id=\"p11\">\n      <span class=\"num\">11</span>\n      <p class=\"indent\">A company called Nortek, Inc., expressed some interest in a merger with Medical Air. On November 8, 1996, Nortek and Medical Air signed a non-binding letter of intent, which proposed that Medical Air's shareholders would receive 500,000 shares of Nortek common stock, worth about seven to ten million dollars. Nortek reserved decision on a final purchase price for Medical Air until it saw whether Medical Air could meet its sales projections for the fourth quarter of 1996. Medical Air quickly scheduled a shareholders' meeting for January 8, 1997. Notices of the meeting and proxy were sent to Medical Air shareholders on December 19, 1996.</p>\n    </div>\n    <div class=\"num\" id=\"p12\">\n      <span class=\"num\">12</span>\n      <p class=\"indent\">On November 19, after receiving Nortek's letter of intent, Rahbany requested from Medical Air the due diligence material provided to Nortek. Under the Investment and Shareholders Agreement, Marwani was entitled to receive any reasonably requested information within five business days. Rahbany says he was particularly interested in any financial forecasts Medical Air had made, because he wanted to assess whether Nortek's interest in Medical Air had a realistic basis. This concern was not unfounded; at trial, Medical Air's financial adviser testified that he warned Medical Air that, once Nortek had seen the due diligence materials, it would attempt to negotiate a lower purchase price.</p>\n    </div>\n    <div class=\"num\" id=\"p13\">\n      <span class=\"num\">13</span>\n      <p class=\"indent\">Rahbany says he repeatedly requested the information over two months, but never received copies of what had been provided to Nortek. Medical Air, in turn, was \"reluctant to produce the documents because\" corporate officials felt that the defendants were \"going fishing\" for evidence for their litigation in the default suit. Medical Air also asked the defendants to identify the specific items they wanted, and the reasons for each. The defendants refused, and reiterated their request for all the due diligence documents. At Medical Air's request, the defendants signed a non-disclosure agreement, agreeing not to disclose any information about the proposed merger.</p>\n    </div>\n    <div class=\"num\" id=\"p14\">\n      <span class=\"num\">14</span>\n      <p class=\"indent\">Medical Air says that it supplied Rahbany with the information that it judged to be necessary for Rahbany's review of the proposed deal, including a <i>listing</i> of the due diligence materials (but not the materials themselves). Medical Air's CEO testified that he did not recall if he ever supplied the defendants with the fourth quarter sales projections provided to Nortek. Medical Air's financial adviser who worked on the merger deal testified that he never provided the defendants with the due diligence materials.</p>\n    </div>\n    <div class=\"num\" id=\"p15\">\n      <span class=\"num\">15</span>\n      <p class=\"indent\">On December 31, 1996, Medical Air sent a draft merger agreement and certain other draft documents to shareholders for review. The defendants say that they were not able to assess the deal in part because the terms, including the purchase price, had not been finalized at that time. According to the Medical Air attorney who worked on the deal, merger terms are never final until the closing, and it is customary for shareholder votes to take place before the merger documents are finalized. The defendants also say that they were unable to assess the viability of the deal because Medical Air's fourth quarter financial results were not yet available. The defendants had certain other problems with the draft documents: the draft merger agreement stated that Marwan Investment's loan would be repaid at the original interest rate, rather than the default interest rate triggered by Medical Air's May 1996 default (a difference of less than $25,000); the shares that Marwani Holding would receive in the proposed merger would not be immediately saleable; and a portion of the shares would be subject to loss if the warranties that Medical Air made in the merger proved to be false. Finally, the draft merger failed to give Marwani Holding preferred shareholder rights, although Medical Air's amended Articles of Organization stated that any merger would make \"appropriate provisions\" to provide the same privileges to preferred stockholders \"as nearly as may be, with respect to any shares of stock or securities\" received in a merger.</p>\n    </div>\n    <div class=\"num\" id=\"p16\">\n      <span class=\"num\">16</span>\n      <p class=\"indent\">Five days before the scheduled vote, the parties met to discuss the proposed merger. At that meeting, the defendants asked for five pieces of information: a statement from Nortek that due diligence was satisfactory; a patent assignment release; an explanation of how the default loan interest rate would be dealt with; a copy of the November financial statements; and a valuation of the company. Medical Air says it provided the November financial statements and a valuation of the defendants' stock under the proposed merger plan (between $1.4 and $1.8 million) to the defendants' counsel on the following day. Rahbany says he was not given sufficient information to determine if that valuation was a credible number, and says that he never received the November financial statements. At that time, the December financial statements were not yet ready. Rahbany admitted at trial that he never reviewed the public records of Nortek to try to assess the basis for Nortek's interest in Medical Air.</p>\n    </div>\n    <div class=\"num\" id=\"p17\">\n      <span class=\"num\">17</span>\n      <p class=\"indent\">Medical Air failed to meet its fourth quarter 1996 projections; it had projected sales of $750,000 for the quarter, but realized only $236,000. Medical Air blames this failure on its problems with the defendants, which it said were distracting its principal officers from business and demoralizing its sales force.</p>\n    </div>\n    <div class=\"num\" id=\"p18\">\n      <span class=\"num\">18</span>\n      <p class=\"indent\">A day or two before the vote, Medical Air's president, Frank Paradise, was told by an associate of his that Marwani planned to vote against the deal. Medical Air says that, as a result of learning that Marwani intended to vote against the deal, it reopened negotiations with Nortek on the day before the scheduled vote. The memory of Nortek's representative was that the negotiations were reopened because Medical Air had failed to meet its fourth quarter projections.</p>\n    </div>\n    <div class=\"num\" id=\"p19\">\n      <span class=\"num\">19</span>\n      <p class=\"indent\">At the January 8 vote, Marwani Holding voted against the merger. All other shareholders voted for the merger. Marwani Holding, holding almost 15% of the shares, was able to single-handedly defeat the merger because Nortek, as part of the proposed merger agreement, had required a minimum of 95% stockholder agreement. Still, the terms of the Investment and Stockholders Agreement appeared to allow Medical Air to proceed with a merger without the defendants' approval if the Medical Air Board of Directors certified that the purchase price met a certain \"qualifying price\" defined in the Agreement. This was never done.<a class=\"footnote\" href=\"#fn1\" id=\"fn1_ref\">1</a> Rahbany testified that he voted against the merger because</p>\n    </div>\n    <div class=\"num\" id=\"p20\">\n      <span class=\"num\">20</span>\n      <p class=\"indent\">I wanted at the same time to know how viable, to find the basis, because I had a fiduciary responsibility to cast a vote, and I had to have a reasonable basis for my action. And when you don't know what you're doing, you don't do anything.</p>\n    </div>\n    <div class=\"num\" id=\"p21\">\n      <span class=\"num\">21</span>\n      <p class=\"indent\">He also testified that he voted against the deal because he did not think that the deal was viable. He admitted that one of the purposes of his vote was to advance the purposes of Marwan Investment, but stated that he \"had in mind the multiple entities that [he] represented all the time and also the separateness all the time.\" After the shareholders' meeting, Marwani's attorney, who tendered the proxy vote, told Medical Air's attorney that the Medical Air principals would make a lot of money from the proposed merger, while Rahbany was coming up short.</p>\n    </div>\n    <div class=\"num\" id=\"p22\">\n      <span class=\"num\">22</span>\n      <p class=\"indent\">Medical Air and Nortek continued negotiations, and later in January 1997 Nortek signed a second letter of intent offering 250,000 shares, while providing that the purchase price would not exceed $6.25 million. The defendants, for their part, continued to request more information. The merger ultimately did not go through, and Medical Air blames this on the legal problems caused by the defendants. Medical Air does not argue, however, that the defendants violated any fiduciary duty with respect to their actions following the January 8 vote.</p>\n    </div>\n    <p>II.</p>\n    <div class=\"num\" id=\"p23\">\n      <span class=\"num\">23</span>\n      <p class=\"indent\">In April 1997, Medical Air filed a diversity suit in the District of Massachusetts, seeking a declaration that it was not in default to the defendants, an injunction against the sale of its assets, and damages for breach of contract, negligence and other claims based on Marwani Holding's vote against the merger. On January 26, 1998, the district court found that, as of May 1996, Medical Air was in default of its responsibilities under the Investment and Stockholders Agreement, and permitted Marwan Investment to sell Medical Air's assets. <i>Medical Air Tech. Corp. v. Marwan Inv., Inc.,</i> No. 97-10764-JLT (D.Mass. Jan. 26, 1998). Medical Air does not appeal this judgment.</p>\n    </div>\n    <div class=\"num\" id=\"p24\">\n      <span class=\"num\">24</span>\n      <p class=\"indent\">The defendants did not immediately enforce their security rights against Medical Air; they say they were waiting to see if Medical Air could find a way to pull itself out of its financial hole. In August 1998, Marwan Investment began foreclosure proceedings against Medical Air. At public auction in November 1998, Marwan Investment bought all of Medical Air's remaining assets with a credit bid of $150,000. Marwan says Medical Air still owed a debt of $1,015,236 to Marwan on the 1996 loan. The defendants then moved for a dismissal of Medical Air's case, arguing that their foreclosure purchase had included Medical Air's rights in this case. The district court denied that motion on June 22, 1999. It also denied a motion by Medical Air's shareholders to intervene.</p>\n    </div>\n    <div class=\"num\" id=\"p25\">\n      <span class=\"num\">25</span>\n      <p class=\"indent\">On August 10, 2000, the defendants filed a motion to strike Medical Air's jury demand. On January 12, 2001, the court heard argument on the jury waiver issue. Medical Air's counsel argued that when Medical Air signed the Security Agreement it did not understand that it was waiving jury trial, but he conceded that the Security Agreement effected a valid waiver of the right to jury with respect to Marwan Investment. Nonetheless, he argued that Medical Air had not waived jury trial for any of the other defendants. The district court judge expressed concern about the feasibility of having a bench trial for one defendant and a simultaneous jury trial for the others. The defendants argued that the plaintiff had presented a claim under Mass. Gen. L. ch. 93A, which could not be considered by a jury, and so the judge \"would have to make findings that would be the mirror findings of\" the jury findings. The court did not conduct an evidentiary hearing (none had been requested), but both parties had submitted affidavits. The court allowed the motion to strike the jury demand without issuing a written order explaining the basis for its decision. However, it appears that the trial judge believed that, in a case arising out of a single transaction and presenting claims against multiple defendants, a waiver against one was a waiver against all.<a class=\"footnote\" href=\"#fn2\" id=\"fn2_ref\">2</a></p>\n    </div>\n    <div class=\"num\" id=\"p26\">\n      <span class=\"num\">26</span>\n      <p class=\"indent\">After the court ruled on the defendants' summary judgment motion, three of Medical Air's claims remained for trial: 1) breach of contract and of the implied covenant of good faith and fair dealing as to MFH and Marwani Holding; 2) breach of fiduciary duty as to Marwani Holding; and 3) tortious interference with contractual and business relations as to all the defendants.</p>\n    </div>\n    <div class=\"num\" id=\"p27\">\n      <span class=\"num\">27</span>\n      <p class=\"indent\">At the conclusion of the four day bench trial, the district court ruled for the defendants on each of Medical Air's remaining claims and entered judgment in the amount of $1,015,236, plus post-trial interest, for Marwan Investment on its counterclaim based on Medical Air's default of the Investment Agreement. It also ruled for the plaintiff on the defendants' good faith counterclaim. <i>Med. Air Tech. Corp. v.</i> <i>Marwan Inv., Inc.,</i> No. 97-10764-JLT (D.Mass. Aug. 21, 2001).</p>\n    </div>\n    <p class=\"center\">\n      <i>III.</i>\n    </p>\n    <div class=\"num\" id=\"p28\">\n      <span class=\"num\">28</span>\n      <p class=\"indent\">On appeal to this court, Medical Air primarily challenges two of the district court's rulings: its order dismissing the jury demand, and its ruling that Marwani Holding was not in breach of its fiduciary duty as a stockholder. The defendants defend the court's rulings on the grounds given by the district court. They also argue, in the alternative, that the district court's judgment should be upheld because Marwan Investment became the assignee of Medical Air's right to pursue this case when it bought all Medical Air's assets in foreclosure.</p>\n    </div>\n    <p class=\"indent\">\n      <i>A. Jury Trial</i>\n    </p>\n    <div class=\"num\" id=\"p29\">\n      <span class=\"num\">29</span>\n      <p class=\"indent\">Medical Air argues that the trial judge erred in granting the defendants' motion to strike Medical Air's jury demand as to its claims against Dr. Rahbany, MFH, and Marwani Holding, because only Marwan Investment was party to the Security Agreement which contained the jury waiver.</p>\n    </div>\n    <div class=\"num\" id=\"p30\">\n      <span class=\"num\">30</span>\n      <p class=\"indent\">The confusion on this issue evident in the record leads us to review basic principles. There is a presumption against denying a jury trial based on waiver, and waivers must be strictly construed.<a class=\"footnote\" href=\"#fn3\" id=\"fn3_ref\">3</a> <i>Aetna Ins. Co. v. Kennedy ex rel. Bogash,</i> 301 U.S. 389, 393, 57 S.Ct. 809, 81 L.Ed. 1177 (1937) (\"[A]s the right of jury trial is fundamental, courts indulge every reasonable presumption against waiver.\"); <i>Paracor Fin., Inc. v. Gen. Elec. Capital Corp.,</i> 96 F.3d 1151, 1166 n. 21 (9th Cir.1996). In a diversity jurisdiction suit, the enforcement of a jury waiver is a question of federal, not state, law. <i>See Simler v. Conner,</i> 372 U.S. 221, 222, 83 S.Ct. 609, 9 L.Ed.2d 691 (1963).</p>\n    </div>\n    <div class=\"num\" id=\"p31\">\n      <span class=\"num\">31</span>\n      <p class=\"indent\">In general, a contractual waiver binds only the parties who sign the contract. <i>See EEOC v. Waffle House, Inc.,</i> 534 U.S. 279, 122 S.Ct. 754, 764, 151 L.Ed.2d 755 (2002) (\"It goes without saying that a contract cannot bind a nonparty.\"). In <i>Waffle House,</i> the Supreme Court held that the EEOC was not bound by an employer-employee contractual arbitration agreement, reasoning that \"[a]bsent some ambiguity in the agreement, ... it is the language of the contract that defines the scope of disputes subject to arbitration,\" and therefore even the federal policy favoring arbitration does not \"authorize[] a court to compel arbitration ... by any parties ... that are not already covered in the agreement.\" <i>Id.</i> at 762.</p>\n    </div>\n    <div class=\"num\" id=\"p32\">\n      <span class=\"num\">32</span>\n      <p class=\"indent\">There are some exceptions to this rule. For instance, some courts have applied a theory of equitable estoppel for suits against non-signatories arising out of the contract itself, reasoning that the party seeking the benefit of a contract could not refuse to be bound by a clause contained within it. <i>E.g., Grigson v. Creative Artists Agency, L.L.C.,</i> 210 F.3d 524, 527-31 (5th Cir.), <i>cert. denied,</i> 531 U.S. 1013, 121 S.Ct. 570, 148 L.Ed.2d 488 (2000); <i>MS Dealer</i> <i>Serv. Corp. v. Franklin,</i> 177 F.3d 942, 947-48 (11th Cir.1999); <i>Hughes Masonry Co. v. Greater Clark County Sch. Bldg. Corp.,</i> 659 F.2d 836, 841 &amp; n. 9 (7th Cir.1981).</p>\n    </div>\n    <div class=\"num\" id=\"p33\">\n      <span class=\"num\">33</span>\n      <p class=\"indent\">In general, though, we look to the plain language of the contract's jury waiver to determine whether it unambiguously covers the claims asserted. In cases where the contractual language is ambiguous, simultaneously executed documents may be relevant as a matter of contractual interpretation. In Massachusetts, \"if the parties execute two or more documents, with a manifested intent that the documents together express their entire agreement, a court reads the documents together, rather than construing each as if it stood alone.\" <i>Donoghue v. IBC USA (Publ'ns), Inc.,</i> 70 F.3d 206, 212 (1st Cir.1995); <i>see also FDIC v. Singh,</i> 977 F.2d 18, 21-22 (1st Cir.1992); <i>Chase Commercial Corp. v. Owen,</i> 32 Mass.App.Ct. 248, 588 N.E.2d 705, 707 (1992); <i>cf. Paracor Fin.,</i> 96 F.3d at 1165 (holding that this is \"a principle of <i>interpretation</i> [which] does not mean that contemporaneously executed documents somehow become a single unified contract binding all signatories to all provisions\").</p>\n    </div>\n    <div class=\"num\" id=\"p34\">\n      <span class=\"num\">34</span>\n      <p class=\"indent\">Even once it is determined that a contractual jury waiver clause does encompass the asserted claims, courts will not enforce the jury waiver unless it was entered into knowingly and voluntarily. <i>See Seaboard Lumber Co. v. United States,</i> 903 F.2d 1560, 1563 (Fed.Cir.1990); <i>Telum, Inc. v. E.F. Hutton Credit Corp.,</i> 859 F.2d 835, 837 (10th Cir.1988) (jury waiver may not be fraudulently induced); <i>K.M.C. Co. v. Irving Tr. Co.,</i> 757 F.2d 752, 755-56 (6th Cir.1985). In cases such as this, where the jury waiver was part of a separate contract, signed only by certain parties to the larger transaction, non-signatory parties seeking enforcement of the waiver may have a more difficult task in showing that the waiver was voluntary and knowing. This is, however, a fact-based inquiry.<a class=\"footnote\" href=\"#fn4\" id=\"fn4_ref\">4</a> <i>See Smart v. Gillette Co. Long-Term Disability Plan,</i> 70 F.3d 173, 182 (1st Cir.1995).</p>\n    </div>\n    <div class=\"num\" id=\"p35\">\n      <span class=\"num\">35</span>\n      <p class=\"indent\">Medical Air has conceded that it made a valid jury waiver with regards to all claims against Marwan Investment. The record is sparse as to the basis for the trial court's ruling. We do not, though, need to decide the issue. As we hold below, no reasonable jury could find liability for breach of fiduciary duty against Marwani Holding nor a causal link between Marwani Holding's vote at the January 8 board meeting and the failure of the proposed merger with Nortek.</p>\n    </div>\n    <div class=\"num\" id=\"p36\">\n      <span class=\"num\">36</span>\n      <p class=\"indent\">Because the core ruling is correct and none of Medical Air's claims could survive a motion for judgment as a matter of law, the jury waiver question is no longer viable. <i>See Segrets v. Gillman Knitwear Co.,</i> 207 F.3d 56, 64 (1st Cir.2000); <i>In re N-500L Cases,</i> 691 F.3d 15, 25 (1st Cir.1982). <i>See generally</i> 9 C. Wright &amp; A. Miller, <i>Federal Practice and Procedure</i> &#167; 2322 n. 6 (2d ed. 1995 &amp; Supp.2002) (collecting cases).</p>\n    </div>\n    <p class=\"indent\">\n      <i>B. Fiduciary Duty</i>\n    </p>\n    <p class=\"indent\">1. Alleged Breach of Duty</p>\n    <div class=\"num\" id=\"p37\">\n      <span class=\"num\">37</span>\n      <p class=\"indent\">Under Massachusetts law, shareholders in a close corporation owe a fiduciary duty of \"utmost good faith and loyalty.\" <i>Zimmerman v. Bogoff,</i> 402 Mass. 650, 524 N.E.2d 849, 853 (1988) (quoting <i>Donahue v. Rodd Electrotype Co. of New England,</i> 367 Mass. 578, 328 N.E.2d 505, 515 (1975)) (internal quotation marks omitted). This is a higher standard than a simple \"good faith and inherent fairness\" standard. <i>Donahue,</i> 328 N.E.2d at 515-16. The Massachusetts Supreme Judicial Court (SJC) has articulated a two-part test for determining if this fiduciary duty has been violated. First, the defendant must show a legitimate business purpose for its action that allegedly is a breach. If the defendant makes such a showing, the burden shifts to the plaintiff to show that \"the proffered legitimate objective could have been achieved through a less harmful, reasonably practicable, alternative mode of action.\" <i>Zimmerman,</i> 524 N.E.2d at 853. Then the court \"must weigh the legitimate business purpose, if any, against the practicability of a less harmful alternative.\" <i>Wilkes v. Springside Nursing Home,</i> 370 Mass. 842, 353 N.E.2d 657, 663 (1976). In applying this test, courts must be sure not to \"unduly hamper ... effectiveness in managing the corporation in the best interests of all concerned.\" <i>Id.</i> Moreover, \"mere errors of judgment\" do not constitute a fiduciary breach. <i>Spiegel v. Beacon Participations,</i> 297 Mass. 398, 8 N.E.2d 895, 904 (1937).</p>\n    </div>\n    <div class=\"num\" id=\"p38\">\n      <span class=\"num\">38</span>\n      <p class=\"indent\"><i>Donahue</i> itself involved an attempt by majority stockholders to freeze out minority shareholders. 328 N.E.2d at 509-11. <i>See generally</i> Peter M. Rosenblum, <i>Corporate Fiduciary Duties in Massachusetts and Delaware, in How to Incorporate and Counsel a Business</i> (Massachusetts Continuing Legal Education, Inc. 1999). By contrast, this case involves actions by 15% minority shareholders. Massachusetts law is clear that minority shareholders in close corporations also have fiduciary responsibilities. <i>See A.W. Chesterton Co. v. Chesterton,</i> 128 F.3d 1, 5-6 (1st Cir.1997); <i>Zimmerman,</i> 524 N.E.2d at 853; <i>Donahue,</i> 328 N.E.2d at 517; <i>Smith v. Atl. Props., Inc.,</i> 12 Mass. App.Ct. 201, 422 N.E.2d 798, 801-02 (1981). <i>Chesterton</i> and <i>Smith</i> involved situations in which unilateral action by minority shareholders would result in dire tax consequences to the majority shareholders. <i>See A.W. Chesterton Co.,</i> 128 F.3d at 3; <i>Smith,</i> 422 N.E.2d at 800. Further, because the financial obligations were owed to the government, there was no market mechanism to determine the consequences of the action. In that sense, the minority shareholders had effective control over one aspect of corporate finances. Here, by contrast, the defendants did not inherently have effective control. Their 15% was needed only because the outside purchasers set as a condition of sale that 95% of the shareholders approve the merger. The <i>Donahue</i> rule itself involves a balancing of legitimate interests, and the scope of the duties owed may depend, in part, on context. <i>See Zimmerman,</i> 524 N.E.2d at 853 (\"[T]he <i>Donahue</i> remedy is not intended to place a strait jacket on legitimate corporate activity.\")</p>\n    </div>\n    <div class=\"num\" id=\"p39\">\n      <span class=\"num\">39</span>\n      <p class=\"indent\">The district court here found that \"[l]acking th[e] information [concerning the basis for the merger, the final terms of the merger, or the price that would be paid], Marwani certainly had a legitimate business reason for voting against the merger\" and, further, that Medical Air's refusal to provide the requested information \"left Marwani with no choice but to vote against merger.\" The district court then found that the only alternative advanced by Medical Air was for Marwani simply to vote for the Nortek merger, an alternative that totally failed to address the problems with the deal itself. This showing does not meet the plaintiff's burden.</p>\n    </div>\n    <div class=\"num\" id=\"p40\">\n      <span class=\"num\">40</span>\n      <p class=\"indent\">Medical Air argues that the district judge improperly construed the Massachusetts law governing fiduciary duty in closely held relationships by holding that Marwani Holding's own business interests could be a proper motivating factor for the vote. It argues that Marwani's vote against the merger was not motivated by legitimate business interests, saying that the vote was really motivated by the defendants' own self-interest &#8212; specifically, that Marwani wanted more of the proceeds of the merger to go to Marwan, rather than the Medical Air principals. It says that Marwani's vote against the merger was intended to pave the way for Marwan's foreclosure of Medical Air's assets, given that Medical Air's financial situation was so desperate in January 1997 that the merger was the only way to salvage the business. Medical Air relies heavily on Rahbany's testimony admitting that he did take Marwan Investment's and Marwani Holding's interests into consideration in his decision. It also relies on the statement that Marwani Holding's counsel allegedly made after the January 8 vote, complaining that Rahbany would not make enough money out of the proposed deal.</p>\n    </div>\n    <div class=\"num\" id=\"p41\">\n      <span class=\"num\">41</span>\n      <p class=\"indent\">Medical Air mischaracterizes the trial court's holding. The trial court held that Marwani Holding had a legitimate purpose in voting against the merger when it had not been provided material information about the merger and perceived a risk that the proposed merger was made of gossamer. That legitimate purpose is not negated if Marwani Holding's vote also coincided with its self-interest.</p>\n    </div>\n    <div class=\"num\" id=\"p42\">\n      <span class=\"num\">42</span>\n      <p class=\"indent\">We reject Medical Air's argument that a minority shareholder may never, under the <i>Donahue</i> rule, take its own interest into account in deciding its vote. Such an argument is both unrealistic and too biased. The SJC has observed that stockholders in a close corporation \"may not act out of avarice, expediency, or self-interest <i>in derogation of</i> their duty of loyalty to the other stockholders and to the corporation.\" <i>Blank v. Chelmsford Ob/Gyn, P.C.,</i> 420 Mass. 404, 649 N.E.2d 1102, 1105 (1995) (emphasis added); <i>see also Donahue,</i> 328 N.E.2d at 515 (using same language). But self-interest may be a proper motive for a stockholder's actions, so long as that interest does not result in acts in derogation of the stockholder's fiduciary duty. The SJC has held that majority stockholders \"have certain rights to what has been termed `selfish ownership' in the corporation which should be balanced against the concept of their fiduciary obligation.\" <i>Wilkes,</i> 353 N.E.2d at 663. We think that principle extends, at least in part, to minority stockholders, although their interests are somewhat different in character. <i>See A.W. Chesterton Co.,</i> 128 F.3d at 7 (noting that minority stockholders may control some aspects of a corporation but not others). Admittedly, there may be tensions between the two types of interests &#8212; loyalty to the corporation and selfish ownership. Difficult cases will arise where the dividing line is not clear. This is not one of those cases.</p>\n    </div>\n    <div class=\"num\" id=\"p43\">\n      <span class=\"num\">43</span>\n      <p class=\"indent\">The district court correctly found that Marwani Holding had shown a legitimate business rationale for the vote against the merger. To begin with, Marwani Holding did lack material information about the proposed merger and Medical Air had failed to provide Marwani Holding with the requested due diligence materials. Marwani Holding also had a suspicion, reasonable in context, that the deal was based on unrealistic assumptions that would ultimately doom it, and that it served only as a distraction from the real problems facing Medical Air. This suspicion was well-founded; Medical Air's CEO admitted at trial that the fourth quarter sales estimates for 1996 provided to Nortek were above what Medical Air had ever accomplished before and far exceeded its actual fourth quarter sales results. These reasons more than suffice to show a legitimate business reason for Marwani's vote.</p>\n    </div>\n    <div class=\"num\" id=\"p44\">\n      <span class=\"num\">44</span>\n      <p class=\"indent\">Upon this showing, the burden shifted to Medical Air to show that there was \"a less harmful, reasonably practicable, alternative mode of action\" other than the vote against the merger. Medical Air has not made any such showing. The district court found that Medical Air's proposed alternative &#8212; that Marwani could have simply voted for the merger &#8212; is not a reasonable and practicable alternative, given Marwani's legitimate concerns about what form the deal would ultimately take, or whether the whole deal was simply a chimera. Its finding was compelled by the evidence.</p>\n    </div>\n    <p class=\"indent\">2. Causation</p>\n    <div class=\"num\" id=\"p45\">\n      <span class=\"num\">45</span>\n      <p class=\"indent\">The defendants argue in the alternative that, even if Marwani Holding had violated a fiduciary duty in voting against the merger, it was not the cause of the merger's failure. We agree. Nortek's CEO testified at trial (through deposition) that after Nortek saw the fourth quarter sales results, it decided that it should pay less than was offered in the original letter of intent and reopened negotiations with Medical Air. The renegotiated offer from Nortek, as expressed in the second letter of intent, provided only half what was offered in the deal before the Board at the January 8 vote. It is clear that Nortek was not willing to go through with the terms of the earlier proposed merger put before the Board that Marwani voted against. Even if Marwani Holding had voted for the proposed merger, it would have made no difference. Medical Air still would have been in the same position as it was after the January 8 vote, negotiating new terms with Nortek. No reasonable jury could find that Marwani Holding's vote was the proximate cause of the demise of the proposed Nortek merger.</p>\n    </div>\n    <p class=\"indent\">\n      <i>C. Other Claims</i>\n    </p>\n    <div class=\"num\" id=\"p46\">\n      <span class=\"num\">46</span>\n      <p class=\"indent\">The plaintiff's other claims are similarly lacking in merit. The remaining questions decided by the district court in the bench trial were: a claim against MFH for breach of the consulting agreement; a breach of the implied covenant of good faith and fair dealing against Marwani Holding based on its vote against the Nortek merger; and tortious interference with contractual relations against Rahbany, MFH, and Marwani Holding for their actions with regard to the Nortek merger.<a class=\"footnote\" href=\"#fn5\" id=\"fn5_ref\">5</a> The latter two claims must fail, for the same reasons that the fiduciary duty claim against Marwan Holding fails. Neither Rahbany nor MFH took any actions with regards to the Nortek deal that were separate from the actions taken by Marwan Holding, discussed above. Medical Air has not presented any evidence to indicate that these actions, rather than Medical Air's inability to meet fourth quarter sales projections, caused the proposed merger before the Board on January 8 to fail. Without causation, there can be no claim for tortious interference, <i>see United Truck Leasing Corp. v. Geltman,</i> 406 Mass. 811, 551 N.E.2d 20, 21 (1990), or for a breach of the implied covenant of good faith and fair dealing, <i>see Druker v. Roland Wm. Jutras Assocs.,</i> 370 Mass. 383, 348 N.E.2d 763, 765 (1976) (\"[I]n every contract there is an implied covenant [of good faith and fair dealing] that neither party shall do anything which will have the effect of destroying or injuring the right of the other party to receive the fruits of the contract....\") (quoting <i>Uproar Co. v. Nat'l Broad. Co.,</i> 81 F.2d 373, 377 (1st Cir.1936)); <i>MacGillivary v. W. Dana Bartlett Ins. Agency of Lexington, Inc.,</i> 14 Mass.App.Ct. 52, 436 N.E.2d 964, 967 (1982).</p>\n    </div>\n    <div class=\"num\" id=\"p47\">\n      <span class=\"num\">47</span>\n      <p class=\"indent\">That leaves only Medical Air's claim that MFH violated its contractual obligations under the consulting agreement. The district court outlined the alleged claim well in its opinion. The consulting agreement required MFH to provide \"financial and strategic corporate planning services\" to Medical Air \"including, by way of example: (i) assisting [Medical Air] in attracting a new senior lender; (ii) evaluating and helping source transactions such as acquisitions, joint ventures and public offerings; and (iii) assisting [Medical Air] in developing financial and operating reporting systems.\" Medical Air's CEO, Stephen Hague, testified that MFH did nothing to help attract a new lender or to develop financial and operating reporting systems. However, Hague also testified that he met on a monthly basis for a few hours with the consultant provided by MFH, as well as speaking with him on the phone for a few hours each month. During these meetings, the consultant reviewed the operation of the company and proposals for the company. According to Hague, the consultant encouraged Medical Air to expand its sales force rapidly; assisted in putting together an expansion plan; recommended and outlined the creation of a business advisory board; and investigated at least one possible acquisition. The consultant also occasionally interviewed or spoke with sales representatives. In addition, Medical Air did effect changes in its accounting procedures during this time period; the consultant was copied on the relevant documents, but the record is not clear as to what his level of participation was.</p>\n    </div>\n    <div class=\"num\" id=\"p48\">\n      <span class=\"num\">48</span>\n      <p class=\"indent\">In August 1996, the consultant who had been working with Medical Air ceased to work for MFH. In September, Medical Air stopped paying the $4,000 per month consultancy fee. In October 1996, Medical Air met with a new individual that MFH had appointed to replace the previous consultant, but that was the last service provided under the consultancy agreement. At this point, Medical Air was already in default of its obligations under the Investment and Stockholders Agreement.<a class=\"footnote\" href=\"#fn6\" id=\"fn6_ref\">6</a></p>\n    </div>\n    <div class=\"num\" id=\"p49\">\n      <span class=\"num\">49</span>\n      <p class=\"indent\">Based on the information provided by Medical Air's CEO, we doubt that Medical Air has presented enough evidence on this claim for it to go to a jury. It is undisputed that the MFH consultant worked with Medical Air throughout the relevant time period and provided input on the business's development. As the district court noted, the fact that the MFH consultant did not achieve all of the goals laid out \"by way of example\" in the consulting agreement did not constitute breach, given how quickly the entire relationship disintegrated and the agreement's lack of any time frame for achieving these goals.</p>\n    </div>\n    <div class=\"num\" id=\"p50\">\n      <span class=\"num\">50</span>\n      <p class=\"indent\">Regardless of the strength of the claim, however, the claim is no longer Medical Air's to make. Marwan Investment purchased all the assets of Medical Air at the foreclosure sale in November 1998. The description of assets included \"all rights, claims, counterclaims, cross-claims, demands, recoveries and defenses in connection with or asserted or which may be asserted by Medical Air in that certain litigation styled <i>Medical Air Technology Corporation v. Marwan Investment</i>... pending in the United States District Court for the District of Massachusetts.\" Under Massachusetts law, claims for breach of contract are generally assignable.<a class=\"footnote\" href=\"#fn7\" id=\"fn7_ref\">7</a> <i>Raymer v. Bay State Nat'l Bank,</i> 384 Mass. 310, 424 N.E.2d 515, 518 (1981); <i>see also SAPC, Inc. v. Lotus Dev. Corp.,</i> 921 F.2d 360 (1st Cir.1990). Although there may be cases in which public policy concerns merit the creation of an exception to that rule when the claim has been involuntarily assigned through a foreclosure sale, this is not such a case. If the claim for breach of the consulting agreement constituted a defense to the defendants' claim of default, or if it would have saved Medical Air as an ongoing concern, than Medical Air should have raised this as a defense to the defendants' summary judgment motion on the default claim. Medical Air did not do so, nor did it raise any contemporaneous objection to the inclusion of its rights in this matter in the assets foreclosure sale.</p>\n    </div>\n    <p class=\"indent\">\n      <i>Conclusion</i>\n    </p>\n    <div class=\"num\" id=\"p51\">\n      <span class=\"num\">51</span>\n      <p class=\"indent\">The district court's decision is <i>affirmed.</i> No costs are awarded.</p>\n    </div>\n    <div class=\"footnotes\">\n      <div class=\"footnote\">\n        <p>Notes:</p>\n      </div>\n      <div class=\"footnote\" id=\"fn1\">\n        <a class=\"footnote\" href=\"#fn1_ref\">1</a>\n        <p> Rahbany testified that one of the reasons justifying his suspicions of the deal was Medical Air's failure to certify the purchase price, although he did not voice that suspicion to Medical Air at the time</p>\n      </div>\n      <div class=\"footnote\" id=\"fn2\">\n        <a class=\"footnote\" href=\"#fn2_ref\">2</a>\n        <p> The court initially noted, \"If I understand correctly, regardless of whether you think &#8212; you talk in terms of integrated documents or anything else, it is very, very clear that the plaintiff waived jury; is that right?\" Medical Air's counsel responded by arguing that the only waiver was in the Security Agreement, and it applied only to Marwan Investment. The judge then said:</p>\n        <p class=\"indent\">But you did waive. With respect to this case, you waived jury.</p>\n        <p class=\"indent\">...</p>\n        <p class=\"indent\">Do you know of any precedent where you can waive with respect to one defendant and not with respect to another? I have never tried a case like that. I would not know how to preside.... I am just talking about within the cast, the traditional cast, of a transaction, one plaintiff, four people, some actual signatory, some by inference, perhaps, but the plaintiff says, I waive jury. Doesn't that count for everything?</p>\n      </div>\n      <div class=\"footnote\" id=\"fn3\">\n        <a class=\"footnote\" href=\"#fn3_ref\">3</a>\n        <p> The circuits are currently split on the question of which party bears the burden of proof as to whether a contractual jury trial waiver was knowing and voluntary<i>See Pierce v. Atchison Topeka &amp; Santa Fe Ry. Co.,</i> 110 F.3d 431, 435 n. 4 (7th Cir.1997) (collecting cases); <i>Hulsey v. West,</i> 966 F.2d 579, 581 (10th Cir.1992). We have not yet ruled on this point, although a district court within this circuit has held that the party seeking to enforce the waiver bears the burden. <i>See Luis Acosta, Inc. v. Citibank, N.A.,</i> 920 F.Supp. 15, 18 (D.P.R. 1996). In the analogous situation of a release of claims against an employer, we have held that the party seeking to enforce the release bears the burden of proof. <i>See Melanson v. Browning-Ferris Indus.,</i> 281 F.3d 272, 276 (1st Cir.2002). We need not resolve the issue here.</p>\n      </div>\n      <div class=\"footnote\" id=\"fn4\">\n        <a class=\"footnote\" href=\"#fn4_ref\">4</a>\n        <p> In analogous situations we have looked to the \"totality of the circumstances,\" including factors such as the waiving party's education and business experience, the respective roles of the parties in determining the terms of the waiver, the clarity of the agreement, the amount of time the waiving party had to consider the waiver, whether the waiving party was represented by counsel, and the consideration offered for the waiver, to determine if the waiver was knowing and voluntary<i>Melanson,</i> 281 F.3d at 276 &amp; n. 4 (waiver of Title VII rights through release of claims against employer); <i>Smart v. Gillette Co. Long-Term Disability Plan,</i> 70 F.3d 173, 181-82 (1st Cir.1995) (waiver of ERISA pension benefits).</p>\n      </div>\n      <div class=\"footnote\" id=\"fn5\">\n        <a class=\"footnote\" href=\"#fn5_ref\">5</a>\n        <p> Medical Air did not appeal the merits of the district court's rulings on these claims. We consider the question only for the purpose of Medical Air's appeal of the denial of a jury trial on all of its claims against MFH, Rahbany and Marwani Holding</p>\n      </div>\n      <div class=\"footnote\" id=\"fn6\">\n        <a class=\"footnote\" href=\"#fn6_ref\">6</a>\n        <p> Medical Air did not argue that MFH's breach was based on the failure to provide ongoing consultancy services after September 1996</p>\n      </div>\n      <div class=\"footnote\" id=\"fn7\">\n        <a class=\"footnote\" href=\"#fn7_ref\">7</a>\n        <p> The defendants have argued that all of Medical Air's claims are assignable, whether or not they sound in contract. We need not decide this point, as we have disposed of Medical Air's other claims on other grounds</p>\n      </div>\n    </div>\n    ",
  "html_lawbox": "",
  "html_columbia": null,
  "html_with_citations": "<p class=\"case_cite\"><span class=\"citation\" data-id=\"200173\"><a href=\"/opinion/200173/medical-air-v-marwan-investment/\"><span class=\"volume\">303</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">11</span></a></span></p>\n    <p class=\"parties\">MEDICAL AIR TECHNOLOGY CORPORATION, Plaintiff, Appellant,<br>v.<br>MARWAN INVESTMENT, INC.; Marwani Holding Company, N.V.; Multifinance Holding Corporation; and Dr. K. Philip Rahbany, Defendants, Appellees.</p>\n    <p class=\"docket\">No. 01-2348.</p>\n    <p class=\"court\">United States Court of Appeals, First Circuit.</p>\n    <p class=\"date\">Heard May 6, 2002.</p>\n    <p class=\"date\">Decided August 14, 2002.</p>\n    <div class=\"prelims\">\n      <p class=\"indent\">Louis N. Massery with whom Massery &amp; Gillis, LLP, Albert L. Farrah Jr., and Corwin &amp; Corwin, LLP were on brief for appellant.</p>\n      <p class=\"indent\">James W. Prendergast with whom Michael G. Bongiorno, Peter J. Kolovos, Barbara Van Gorder, and Hale and Dorr LLP were on brief for appellees.</p>\n      <p class=\"indent\">Before TORRUELLA, Circuit Judge, COFFIN, Senior Circuit Judge, and LYNCH, Circuit Judge.</p>\n      <p class=\"indent\">LYNCH, Circuit Judge.</p>\n    </div>\n    <div class=\"num\" id=\"p1\">\n      <span class=\"num\">1</span>\n      <p class=\"indent\">Medical Air Technology appeals a judgment rendered after a bench trial involving a closely held corporation's financial travails and allegations of fiduciary violations by one of its investors. The plaintiff Medical Air, the closely held corporation, presents two claims of error: 1) that the district court applied the wrong legal standard for a shareholder's fiduciary duty to a closely held corporation; and 2) that the district court judge improperly found that Medical Air had waived its right to a jury trial against all of the defendants, and not just one of the defendants. We affirm the district court's judgment, because the defendants were not in breach of any fiduciary duties owed, and because there was no evidence that the defendants' actions caused the harm that Medical Air suffered. The reasoning we use in affirming that judgment renders Medical Air's claim, if any, to a jury trial irrelevant and disposes of all claims in the case.</p>\n    </div>\n    <p class=\"center\">\n      <i>I.</i>\n    </p>\n    <div class=\"num\" id=\"p2\">\n      <span class=\"num\">2</span>\n      <p class=\"indent\">Medical Air is a closely held corporation, incorporated in 1992, which sold air purification equipment to medical facilities. In search of financing, Medical Air executed an agreement in January 1996 with Multifinance Holding Company (\"MFH\"). MFH used two related holding companies, Marwan Investment and Marwani Holding Company, to structure the deal. Dr. Kalil Philip Rahbany was the President of MFH and an agent of Marwan Investment and Marwani Holding.</p>\n    </div>\n    <div class=\"num\" id=\"p3\">\n      <span class=\"num\">3</span>\n      <p class=\"indent\">The agreement resulted in a total of $1.375 million in funding for Medical Air: a $625,000 loan from Marwan Investment and a $750,000 purchase of preferred stock by Marwani Holding. Medical Air signed an Investment and Stockholders Agreement, a Secured Promissory Note for the loan, and a Security Agreement. It also amended its Articles of Organization. The Security Agreement was executed by Medical Air and Marwan Investment only and served to secure the loan from Marwan Investment. It contained a jury waiver, which provided that:</p>\n    </div>\n    <div class=\"num\" id=\"p4\">\n      <span class=\"num\">4</span>\n      <p class=\"indent\">Grantor [Medical Air] and Marwan hereby waive their respective rights to a jury trial of any claim or cause of action based upon or arising out of this Security Agreement, the Investment and Stockholders Agreement or any other agreement evidencing, securing, or otherwise executed in connection with any Obligations.</p>\n    </div>\n    <div class=\"num\" id=\"p5\">\n      <span class=\"num\">5</span>\n      <p class=\"indent\">The Security Agreement defines \"Obligations\" as:</p>\n    </div>\n    <div class=\"num\" id=\"p6\">\n      <span class=\"num\">6</span>\n      <p class=\"indent\">any and all indebtedness, obligations, agreements and liabilities of either Grantor to Marwan including, without limitation, all indebtedness and obligations of Grantor under the Investment and Stockholders Agreement, the Notes executed pursuant thereto, and any other indebtedness, obligations, agreements and liabilities of Grantor to Marwan of every kind and description, direct or indirect, absolute or contingent, due or to become due, regardless of how they arose or were acquired, now existing or hereafter arising.</p>\n    </div>\n    <div class=\"num\" id=\"p7\">\n      <span class=\"num\">7</span>\n      <p class=\"indent\">MFH and Medical Air also entered into a Consulting Agreement, under which MFH would provide specified consulting services to Medical Air for the fee of $4,000 a month. Medical Air's President, Frank Paradise, took the lead in negotiating the deal. Medical Air was represented by counsel in the negotiations and the drafting of the investment agreements, as were the defendants.</p>\n    </div>\n    <div class=\"num\" id=\"p8\">\n      <span class=\"num\">8</span>\n      <p class=\"indent\">Within a few months, the relationship had soured. In May, 1996, Medical Air failed to meet the minimum net worth and net working capital requirements to which it had agreed in the Investment and Stockholders Agreement. The Investment and Stockholders Agreement specified that if Medical Air defaulted on these terms, then Marwan Investment could accelerate the loan, making it immediately payable, and Marwani Holding could immediately seek to redeem its stock. If Medical Air failed to redeem the stock within six months, under the amended Articles of Organization, its Board of Directors would double in size plus one, and Marwani Holding could appoint the new Board members. Thus, if the stock was not redeemed after default, control of Medical Air would shift to Marwani Holding.</p>\n    </div>\n    <div class=\"num\" id=\"p9\">\n      <span class=\"num\">9</span>\n      <p class=\"indent\">Medical Air attempted to obtain the defendants' permission to issue additional stock in the hope that increased funding would allow it to expand its production capacity to take advantage of some inchoate sales opportunities. The defendants opposed this plan, fearing it would dilute their interest in the company. Medical Air then presented the defendants with the possibility of a buy-out by an outside investor, but the defendants were not interested.</p>\n    </div>\n    <div class=\"num\" id=\"p10\">\n      <span class=\"num\">10</span>\n      <p class=\"indent\">Instead, between July 8 and August 15, 1996, the defendants sent three separate notices of default to Medical Air and threatened litigation. Efforts were made to restructure the business, but these were unsuccessful. In the August 15 notice, Marwan Investment exercised its right to demand acceleration of the loan and, the following month, Marwani Holding requested that Medical Air redeem its stock. In response, Medical Air began to look for a new investor to buy out the defendants. During this time, the defendants chose not to exercise their security rights against Medical Air, waiting to see if Medical Air could secure new funding. The parties agree that, by the fall of 1996, Medical Air was out of money to fill orders and, to put it mildly, not doing well.</p>\n    </div>\n    <div class=\"num\" id=\"p11\">\n      <span class=\"num\">11</span>\n      <p class=\"indent\">A company called Nortek, Inc., expressed some interest in a merger with Medical Air. On November 8, 1996, Nortek and Medical Air signed a non-binding letter of intent, which proposed that Medical Air's shareholders would receive 500,000 shares of Nortek common stock, worth about seven to ten million dollars. Nortek reserved decision on a final purchase price for Medical Air until it saw whether Medical Air could meet its sales projections for the fourth quarter of 1996. Medical Air quickly scheduled a shareholders' meeting for January 8, 1997. Notices of the meeting and proxy were sent to Medical Air shareholders on December 19, 1996.</p>\n    </div>\n    <div class=\"num\" id=\"p12\">\n      <span class=\"num\">12</span>\n      <p class=\"indent\">On November 19, after receiving Nortek's letter of intent, Rahbany requested from Medical Air the due diligence material provided to Nortek. Under the Investment and Shareholders Agreement, Marwani was entitled to receive any reasonably requested information within five business days. Rahbany says he was particularly interested in any financial forecasts Medical Air had made, because he wanted to assess whether Nortek's interest in Medical Air had a realistic basis. This concern was not unfounded; at trial, Medical Air's financial adviser testified that he warned Medical Air that, once Nortek had seen the due diligence materials, it would attempt to negotiate a lower purchase price.</p>\n    </div>\n    <div class=\"num\" id=\"p13\">\n      <span class=\"num\">13</span>\n      <p class=\"indent\">Rahbany says he repeatedly requested the information over two months, but never received copies of what had been provided to Nortek. Medical Air, in turn, was \"reluctant to produce the documents because\" corporate officials felt that the defendants were \"going fishing\" for evidence for their litigation in the default suit. Medical Air also asked the defendants to identify the specific items they wanted, and the reasons for each. The defendants refused, and reiterated their request for all the due diligence documents. At Medical Air's request, the defendants signed a non-disclosure agreement, agreeing not to disclose any information about the proposed merger.</p>\n    </div>\n    <div class=\"num\" id=\"p14\">\n      <span class=\"num\">14</span>\n      <p class=\"indent\">Medical Air says that it supplied Rahbany with the information that it judged to be necessary for Rahbany's review of the proposed deal, including a <i>listing</i> of the due diligence materials (but not the materials themselves). Medical Air's CEO testified that he did not recall if he ever supplied the defendants with the fourth quarter sales projections provided to Nortek. Medical Air's financial adviser who worked on the merger deal testified that he never provided the defendants with the due diligence materials.</p>\n    </div>\n    <div class=\"num\" id=\"p15\">\n      <span class=\"num\">15</span>\n      <p class=\"indent\">On December 31, 1996, Medical Air sent a draft merger agreement and certain other draft documents to shareholders for review. The defendants say that they were not able to assess the deal in part because the terms, including the purchase price, had not been finalized at that time. According to the Medical Air attorney who worked on the deal, merger terms are never final until the closing, and it is customary for shareholder votes to take place before the merger documents are finalized. The defendants also say that they were unable to assess the viability of the deal because Medical Air's fourth quarter financial results were not yet available. The defendants had certain other problems with the draft documents: the draft merger agreement stated that Marwan Investment's loan would be repaid at the original interest rate, rather than the default interest rate triggered by Medical Air's May 1996 default (a difference of less than $25,000); the shares that Marwani Holding would receive in the proposed merger would not be immediately saleable; and a portion of the shares would be subject to loss if the warranties that Medical Air made in the merger proved to be false. Finally, the draft merger failed to give Marwani Holding preferred shareholder rights, although Medical Air's amended Articles of Organization stated that any merger would make \"appropriate provisions\" to provide the same privileges to preferred stockholders \"as nearly as may be, with respect to any shares of stock or securities\" received in a merger.</p>\n    </div>\n    <div class=\"num\" id=\"p16\">\n      <span class=\"num\">16</span>\n      <p class=\"indent\">Five days before the scheduled vote, the parties met to discuss the proposed merger. At that meeting, the defendants asked for five pieces of information: a statement from Nortek that due diligence was satisfactory; a patent assignment release; an explanation of how the default loan interest rate would be dealt with; a copy of the November financial statements; and a valuation of the company. Medical Air says it provided the November financial statements and a valuation of the defendants' stock under the proposed merger plan (between $1.4 and $1.8 million) to the defendants' counsel on the following day. Rahbany says he was not given sufficient information to determine if that valuation was a credible number, and says that he never received the November financial statements. At that time, the December financial statements were not yet ready. Rahbany admitted at trial that he never reviewed the public records of Nortek to try to assess the basis for Nortek's interest in Medical Air.</p>\n    </div>\n    <div class=\"num\" id=\"p17\">\n      <span class=\"num\">17</span>\n      <p class=\"indent\">Medical Air failed to meet its fourth quarter 1996 projections; it had projected sales of $750,000 for the quarter, but realized only $236,000. Medical Air blames this failure on its problems with the defendants, which it said were distracting its principal officers from business and demoralizing its sales force.</p>\n    </div>\n    <div class=\"num\" id=\"p18\">\n      <span class=\"num\">18</span>\n      <p class=\"indent\">A day or two before the vote, Medical Air's president, Frank Paradise, was told by an associate of his that Marwani planned to vote against the deal. Medical Air says that, as a result of learning that Marwani intended to vote against the deal, it reopened negotiations with Nortek on the day before the scheduled vote. The memory of Nortek's representative was that the negotiations were reopened because Medical Air had failed to meet its fourth quarter projections.</p>\n    </div>\n    <div class=\"num\" id=\"p19\">\n      <span class=\"num\">19</span>\n      <p class=\"indent\">At the January 8 vote, Marwani Holding voted against the merger. All other shareholders voted for the merger. Marwani Holding, holding almost 15% of the shares, was able to single-handedly defeat the merger because Nortek, as part of the proposed merger agreement, had required a minimum of 95% stockholder agreement. Still, the terms of the Investment and Stockholders Agreement appeared to allow Medical Air to proceed with a merger without the defendants' approval if the Medical Air Board of Directors certified that the purchase price met a certain \"qualifying price\" defined in the Agreement. This was never done.<a class=\"footnote\" href=\"#fn1\" id=\"fn1_ref\">1</a> Rahbany testified that he voted against the merger because</p>\n    </div>\n    <div class=\"num\" id=\"p20\">\n      <span class=\"num\">20</span>\n      <p class=\"indent\">I wanted at the same time to know how viable, to find the basis, because I had a fiduciary responsibility to cast a vote, and I had to have a reasonable basis for my action. And when you don't know what you're doing, you don't do anything.</p>\n    </div>\n    <div class=\"num\" id=\"p21\">\n      <span class=\"num\">21</span>\n      <p class=\"indent\">He also testified that he voted against the deal because he did not think that the deal was viable. He admitted that one of the purposes of his vote was to advance the purposes of Marwan Investment, but stated that he \"had in mind the multiple entities that [he] represented all the time and also the separateness all the time.\" After the shareholders' meeting, Marwani's attorney, who tendered the proxy vote, told Medical Air's attorney that the Medical Air principals would make a lot of money from the proposed merger, while Rahbany was coming up short.</p>\n    </div>\n    <div class=\"num\" id=\"p22\">\n      <span class=\"num\">22</span>\n      <p class=\"indent\">Medical Air and Nortek continued negotiations, and later in January 1997 Nortek signed a second letter of intent offering 250,000 shares, while providing that the purchase price would not exceed $6.25 million. The defendants, for their part, continued to request more information. The merger ultimately did not go through, and Medical Air blames this on the legal problems caused by the defendants. Medical Air does not argue, however, that the defendants violated any fiduciary duty with respect to their actions following the January 8 vote.</p>\n    </div>\n    <p>II.</p>\n    <div class=\"num\" id=\"p23\">\n      <span class=\"num\">23</span>\n      <p class=\"indent\">In April 1997, Medical Air filed a diversity suit in the District of Massachusetts, seeking a declaration that it was not in default to the defendants, an injunction against the sale of its assets, and damages for breach of contract, negligence and other claims based on Marwani Holding's vote against the merger. On January 26, 1998, the district court found that, as of May 1996, Medical Air was in default of its responsibilities under the Investment and Stockholders Agreement, and permitted Marwan Investment to sell Medical Air's assets. <i>Medical Air Tech. Corp. v. Marwan Inv., Inc.,</i> No. 97-10764-JLT (D.Mass. Jan. 26, 1998). Medical Air does not appeal this judgment.</p>\n    </div>\n    <div class=\"num\" id=\"p24\">\n      <span class=\"num\">24</span>\n      <p class=\"indent\">The defendants did not immediately enforce their security rights against Medical Air; they say they were waiting to see if Medical Air could find a way to pull itself out of its financial hole. In August 1998, Marwan Investment began foreclosure proceedings against Medical Air. At public auction in November 1998, Marwan Investment bought all of Medical Air's remaining assets with a credit bid of $150,000. Marwan says Medical Air still owed a debt of $1,015,236 to Marwan on the 1996 loan. The defendants then moved for a dismissal of Medical Air's case, arguing that their foreclosure purchase had included Medical Air's rights in this case. The district court denied that motion on June 22, 1999. It also denied a motion by Medical Air's shareholders to intervene.</p>\n    </div>\n    <div class=\"num\" id=\"p25\">\n      <span class=\"num\">25</span>\n      <p class=\"indent\">On August 10, 2000, the defendants filed a motion to strike Medical Air's jury demand. On January 12, 2001, the court heard argument on the jury waiver issue. Medical Air's counsel argued that when Medical Air signed the Security Agreement it did not understand that it was waiving jury trial, but he conceded that the Security Agreement effected a valid waiver of the right to jury with respect to Marwan Investment. Nonetheless, he argued that Medical Air had not waived jury trial for any of the other defendants. The district court judge expressed concern about the feasibility of having a bench trial for one defendant and a simultaneous jury trial for the others. The defendants argued that the plaintiff had presented a claim under Mass. Gen. L. ch. 93A, which could not be considered by a jury, and so the judge \"would have to make findings that would be the mirror findings of\" the jury findings. The court did not conduct an evidentiary hearing (none had been requested), but both parties had submitted affidavits. The court allowed the motion to strike the jury demand without issuing a written order explaining the basis for its decision. However, it appears that the trial judge believed that, in a case arising out of a single transaction and presenting claims against multiple defendants, a waiver against one was a waiver against all.<a class=\"footnote\" href=\"#fn2\" id=\"fn2_ref\">2</a></p>\n    </div>\n    <div class=\"num\" id=\"p26\">\n      <span class=\"num\">26</span>\n      <p class=\"indent\">After the court ruled on the defendants' summary judgment motion, three of Medical Air's claims remained for trial: 1) breach of contract and of the implied covenant of good faith and fair dealing as to MFH and Marwani Holding; 2) breach of fiduciary duty as to Marwani Holding; and 3) tortious interference with contractual and business relations as to all the defendants.</p>\n    </div>\n    <div class=\"num\" id=\"p27\">\n      <span class=\"num\">27</span>\n      <p class=\"indent\">At the conclusion of the four day bench trial, the district court ruled for the defendants on each of Medical Air's remaining claims and entered judgment in the amount of $1,015,236, plus post-trial interest, for Marwan Investment on its counterclaim based on Medical Air's default of the Investment Agreement. It also ruled for the plaintiff on the defendants' good faith counterclaim. <i>Med. Air Tech. Corp. v.</i> <i>Marwan Inv., Inc.,</i> No. 97-10764-JLT (D.Mass. Aug. 21, 2001).</p>\n    </div>\n    <p class=\"center\">\n      <i>III.</i>\n    </p>\n    <div class=\"num\" id=\"p28\">\n      <span class=\"num\">28</span>\n      <p class=\"indent\">On appeal to this court, Medical Air primarily challenges two of the district court's rulings: its order dismissing the jury demand, and its ruling that Marwani Holding was not in breach of its fiduciary duty as a stockholder. The defendants defend the court's rulings on the grounds given by the district court. They also argue, in the alternative, that the district court's judgment should be upheld because Marwan Investment became the assignee of Medical Air's right to pursue this case when it bought all Medical Air's assets in foreclosure.</p>\n    </div>\n    <p class=\"indent\">\n      <i>A. Jury Trial</i>\n    </p>\n    <div class=\"num\" id=\"p29\">\n      <span class=\"num\">29</span>\n      <p class=\"indent\">Medical Air argues that the trial judge erred in granting the defendants' motion to strike Medical Air's jury demand as to its claims against Dr. Rahbany, MFH, and Marwani Holding, because only Marwan Investment was party to the Security Agreement which contained the jury waiver.</p>\n    </div>\n    <div class=\"num\" id=\"p30\">\n      <span class=\"num\">30</span>\n      <p class=\"indent\">The confusion on this issue evident in the record leads us to review basic principles. There is a presumption against denying a jury trial based on waiver, and waivers must be strictly construed.<a class=\"footnote\" href=\"#fn3\" id=\"fn3_ref\">3</a> <i>Aetna Ins. Co. v. Kennedy ex rel. Bogash,</i> <span class=\"citation\" data-id=\"102830\"><a href=\"/opinion/102830/aetna-ins-co-v-kennedy-ex-rel-bogash/\"><span class=\"volume\">301</span> <span class=\"reporter\">U.S.</span> <span class=\"page\">389</span></a></span>, 393, <span class=\"citation no-link\"><span class=\"volume\">57</span> <span class=\"reporter\">S. Ct.</span> <span class=\"page\">809</span></span>, <span class=\"citation no-link\"><span class=\"volume\">81</span> <span class=\"reporter\">L. Ed.</span> <span class=\"page\">1177</span></span> (1937) (\"[A]s the right of jury trial is fundamental, courts indulge every reasonable presumption against waiver.\"); <i>Paracor Fin., Inc. v. Gen. Elec. Capital Corp.,</i> <span class=\"citation\" data-id=\"726747\"><a href=\"/opinion/726747/blue-sky-l-rep-p-74088-fed-sec-l-rep-p-99315-96-daily-journal/\"><span class=\"volume\">96</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">1151</span></a></span>, 1166 n. 21 (9th Cir.1996). In a diversity jurisdiction suit, the enforcement of a jury waiver is a question of federal, not state, law. <i>See Simler v. Conner,</i> <span class=\"citation\" data-id=\"106535\"><a href=\"/opinion/106535/simler-v-conner/\"><span class=\"volume\">372</span> <span class=\"reporter\">U.S.</span> <span class=\"page\">221</span></a></span>, 222, <span class=\"citation\" data-id=\"106535\"><a href=\"/opinion/106535/simler-v-conner/\"><span class=\"volume\">83</span> <span class=\"reporter\">S. Ct.</span> <span class=\"page\">609</span></a></span>, <span class=\"citation\" data-id=\"106535\"><a href=\"/opinion/106535/simler-v-conner/\"><span class=\"volume\">9</span> <span class=\"reporter\">L. Ed. 2d</span> <span class=\"page\">691</span></a></span> (1963).</p>\n    </div>\n    <div class=\"num\" id=\"p31\">\n      <span class=\"num\">31</span>\n      <p class=\"indent\">In general, a contractual waiver binds only the parties who sign the contract. <i>See EEOC v. Waffle House, Inc.,</i> <span class=\"citation\" data-id=\"118475\"><a href=\"/opinion/118475/eeoc-v-waffle-house-inc/\"><span class=\"volume\">534</span> <span class=\"reporter\">U.S.</span> <span class=\"page\">279</span></a></span>, <span class=\"citation\" data-id=\"118475\"><a href=\"/opinion/118475/eeoc-v-waffle-house-inc/\"><span class=\"volume\">122</span> <span class=\"reporter\">S. Ct.</span> <span class=\"page\">754</span></a></span>, 764, <span class=\"citation\" data-id=\"118475\"><a href=\"/opinion/118475/eeoc-v-waffle-house-inc/\"><span class=\"volume\">151</span> <span class=\"reporter\">L. Ed. 2d</span> <span class=\"page\">755</span></a></span> (2002) (\"It goes without saying that a contract cannot bind a nonparty.\"). In <i>Waffle House,</i> the Supreme Court held that the EEOC was not bound by an employer-employee contractual arbitration agreement, reasoning that \"[a]bsent some ambiguity in the agreement, ... it is the language of the contract that defines the scope of disputes subject to arbitration,\" and therefore even the federal policy favoring arbitration does not \"authorize[] a court to compel arbitration ... by any parties ... that are not already covered in the agreement.\" <i>Id.</i> at 762.</p>\n    </div>\n    <div class=\"num\" id=\"p32\">\n      <span class=\"num\">32</span>\n      <p class=\"indent\">There are some exceptions to this rule. For instance, some courts have applied a theory of equitable estoppel for suits against non-signatories arising out of the contract itself, reasoning that the party seeking the benefit of a contract could not refuse to be bound by a clause contained within it. <i>E.g., Grigson v. Creative Artists Agency, L.L.C.,</i> <span class=\"citation\" data-id=\"20718\"><a href=\"/opinion/20718/grigson-v-creative-artists/\"><span class=\"volume\">210</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">524</span></a></span>, 527-31 (5th Cir.), <i>cert. denied,</i> <span class=\"citation no-link\"><span class=\"volume\">531</span> <span class=\"reporter\">U.S.</span> <span class=\"page\">1013</span></span>, <span class=\"citation no-link\"><span class=\"volume\">121</span> <span class=\"reporter\">S. Ct.</span> <span class=\"page\">570</span></span>, <span class=\"citation no-link\"><span class=\"volume\">148</span> <span class=\"reporter\">L. Ed. 2d</span> <span class=\"page\">488</span></span> (2000); <i>MS Dealer</i> <i>Serv. Corp. v. Franklin,</i> <span class=\"citation no-link\"><span class=\"volume\">177</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">942</span></span>, 947-48 (11th Cir.1999); <i>Hughes Masonry Co. v. Greater Clark County Sch. Bldg. Corp.,</i> <span class=\"citation\" data-id=\"394161\"><a href=\"/opinion/394161/hughes-masonry-company-inc-v-greater-clark-county-school-building/\"><span class=\"volume\">659</span> <span class=\"reporter\">F.2d</span> <span class=\"page\">836</span></a></span>, 841 &amp; n. 9 (7th Cir.1981).</p>\n    </div>\n    <div class=\"num\" id=\"p33\">\n      <span class=\"num\">33</span>\n      <p class=\"indent\">In general, though, we look to the plain language of the contract's jury waiver to determine whether it unambiguously covers the claims asserted. In cases where the contractual language is ambiguous, simultaneously executed documents may be relevant as a matter of contractual interpretation. In Massachusetts, \"if the parties execute two or more documents, with a manifested intent that the documents together express their entire agreement, a court reads the documents together, rather than construing each as if it stood alone.\" <i>Donoghue v. IBC USA (Publ'ns), Inc.,</i> <span class=\"citation\" data-id=\"196436\"><a href=\"/opinion/196436/donoghue-v-ibc-usa/\"><span class=\"volume\">70</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">206</span></a></span>, 212 (1st Cir.1995); <i>see also FDIC v. Singh,</i> <span class=\"citation\" data-id=\"592214\"><a href=\"/opinion/592214/federal-deposit-insurance-corporation-v-pritam-singh/\"><span class=\"volume\">977</span> <span class=\"reporter\">F.2d</span> <span class=\"page\">18</span></a></span>, 21-22 (1st Cir.1992); <i>Chase Commercial Corp. v. Owen,</i> 32 Mass.App.Ct. 248, <span class=\"citation\" data-id=\"2219112\"><a href=\"/opinion/2219112/chase-commercial-corp-v-owen/\"><span class=\"volume\">588</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">705</span></a></span>, 707 (1992); <i>cf. Paracor Fin.,</i> 96 F.3d at 1165 (holding that this is \"a principle of <i>interpretation</i> [which] does not mean that contemporaneously executed documents somehow become a single unified contract binding all signatories to all provisions\").</p>\n    </div>\n    <div class=\"num\" id=\"p34\">\n      <span class=\"num\">34</span>\n      <p class=\"indent\">Even once it is determined that a contractual jury waiver clause does encompass the asserted claims, courts will not enforce the jury waiver unless it was entered into knowingly and voluntarily. <i>See Seaboard Lumber Co. v. United States,</i> <span class=\"citation\" data-id=\"542054\"><a href=\"/opinion/542054/seaboard-lumber-company-wt-burgess-logging-co-inc-big-flat-timber/\"><span class=\"volume\">903</span> <span class=\"reporter\">F.2d</span> <span class=\"page\">1560</span></a></span>, 1563 (Fed.Cir.1990); <i>Telum, Inc. v. E.F. Hutton Credit Corp.,</i> <span class=\"citation\" data-id=\"512976\"><a href=\"/opinion/512976/telum-inc-a-nebraska-corporation-earl-k-cook-and-carl-r-king/\"><span class=\"volume\">859</span> <span class=\"reporter\">F.2d</span> <span class=\"page\">835</span></a></span>, 837 (10th Cir.1988) (jury waiver may not be fraudulently induced); <i>K.M.C. Co. v. Irving Tr. Co.,</i> <span class=\"citation\" data-id=\"449501\"><a href=\"/opinion/449501/kmc-co-inc-v-irving-trust-company/\"><span class=\"volume\">757</span> <span class=\"reporter\">F.2d</span> <span class=\"page\">752</span></a></span>, 755-56 (6th Cir.1985). In cases such as this, where the jury waiver was part of a separate contract, signed only by certain parties to the larger transaction, non-signatory parties seeking enforcement of the waiver may have a more difficult task in showing that the waiver was voluntary and knowing. This is, however, a fact-based inquiry.<a class=\"footnote\" href=\"#fn4\" id=\"fn4_ref\">4</a> <i>See Smart v. Gillette Co. Long-Term Disability Plan,</i> <span class=\"citation\" data-id=\"196424\"><a href=\"/opinion/196424/smart-v-the-gillette-company/\"><span class=\"volume\">70</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">173</span></a></span>, 182 (1st Cir.1995).</p>\n    </div>\n    <div class=\"num\" id=\"p35\">\n      <span class=\"num\">35</span>\n      <p class=\"indent\">Medical Air has conceded that it made a valid jury waiver with regards to all claims against Marwan Investment. The record is sparse as to the basis for the trial court's ruling. We do not, though, need to decide the issue. As we hold below, no reasonable jury could find liability for breach of fiduciary duty against Marwani Holding nor a causal link between Marwani Holding's vote at the January 8 board meeting and the failure of the proposed merger with Nortek.</p>\n    </div>\n    <div class=\"num\" id=\"p36\">\n      <span class=\"num\">36</span>\n      <p class=\"indent\">Because the core ruling is correct and none of Medical Air's claims could survive a motion for judgment as a matter of law, the jury waiver question is no longer viable. <i>See Segrets v. Gillman Knitwear Co.,</i> <span class=\"citation\" data-id=\"768061\"><a href=\"/opinion/768061/segrets-inc-v-gillman-knitwear-co-inc/\"><span class=\"volume\">207</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">56</span></a></span>, 64 (1st Cir.2000); <i>In re N-500L Cases,</i> <span class=\"citation no-link\"><span class=\"volume\">691</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">15</span></span>, 25 (1st Cir.1982). <i>See generally</i> 9 C. Wright &amp; A. Miller, <i>Federal Practice and Procedure</i> &#167; 2322 n. 6 (2d ed. 1995 &amp; Supp.2002) (collecting cases).</p>\n    </div>\n    <p class=\"indent\">\n      <i>B. Fiduciary Duty</i>\n    </p>\n    <p class=\"indent\">1. Alleged Breach of Duty</p>\n    <div class=\"num\" id=\"p37\">\n      <span class=\"num\">37</span>\n      <p class=\"indent\">Under Massachusetts law, shareholders in a close corporation owe a fiduciary duty of \"utmost good faith and loyalty.\" <i>Zimmerman v. Bogoff,</i> <span class=\"citation\" data-id=\"2063601\"><a href=\"/opinion/2063601/zimmerman-v-bogoff/\"><span class=\"volume\">402</span> <span class=\"reporter\">Mass.</span> <span class=\"page\">650</span></a></span>, <span class=\"citation\" data-id=\"2063601\"><a href=\"/opinion/2063601/zimmerman-v-bogoff/\"><span class=\"volume\">524</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">849</span></a></span>, 853 (1988) (quoting <i>Donahue v. Rodd Electrotype Co. of New England,</i> <span class=\"citation\" data-id=\"2059671\"><a href=\"/opinion/2059671/donahue-v-rodd-electrotype-co-of-new-england-inc/\"><span class=\"volume\">367</span> <span class=\"reporter\">Mass.</span> <span class=\"page\">578</span></a></span>, <span class=\"citation\" data-id=\"2059671\"><a href=\"/opinion/2059671/donahue-v-rodd-electrotype-co-of-new-england-inc/\"><span class=\"volume\">328</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">505</span></a></span>, 515 (1975)) (internal quotation marks omitted). This is a higher standard than a simple \"good faith and inherent fairness\" standard. <i>Donahue,</i> 328 N.E.2d at 515-16. The Massachusetts Supreme Judicial Court (SJC) has articulated a two-part test for determining if this fiduciary duty has been violated. First, the defendant must show a legitimate business purpose for its action that allegedly is a breach. If the defendant makes such a showing, the burden shifts to the plaintiff to show that \"the proffered legitimate objective could have been achieved through a less harmful, reasonably practicable, alternative mode of action.\" <i>Zimmerman,</i> 524 N.E.2d at 853. Then the court \"must weigh the legitimate business purpose, if any, against the practicability of a less harmful alternative.\" <i>Wilkes v. Springside Nursing Home,</i> <span class=\"citation\" data-id=\"2073798\"><a href=\"/opinion/2073798/wilkes-v-springside-nursing-home-inc/\"><span class=\"volume\">370</span> <span class=\"reporter\">Mass.</span> <span class=\"page\">842</span></a></span>, <span class=\"citation\" data-id=\"2073798\"><a href=\"/opinion/2073798/wilkes-v-springside-nursing-home-inc/\"><span class=\"volume\">353</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">657</span></a></span>, 663 (1976). In applying this test, courts must be sure not to \"unduly hamper ... effectiveness in managing the corporation in the best interests of all concerned.\" <i>Id.</i> Moreover, \"mere errors of judgment\" do not constitute a fiduciary breach. <i>Spiegel v. Beacon Participations,</i> <span class=\"citation no-link\"><span class=\"volume\">297</span> <span class=\"reporter\">Mass.</span> <span class=\"page\">398</span></span>, <span class=\"citation no-link\"><span class=\"volume\">8</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">895</span></span>, 904 (1937).</p>\n    </div>\n    <div class=\"num\" id=\"p38\">\n      <span class=\"num\">38</span>\n      <p class=\"indent\"><i>Donahue</i> itself involved an attempt by majority stockholders to freeze out minority shareholders. 328 N.E.2d at 509-11. <i>See generally</i> Peter M. Rosenblum, <i>Corporate Fiduciary Duties in Massachusetts and Delaware, in How to Incorporate and Counsel a Business</i> (Massachusetts Continuing Legal Education, Inc. 1999). By contrast, this case involves actions by 15% minority shareholders. Massachusetts law is clear that minority shareholders in close corporations also have fiduciary responsibilities. <i>See A.W. Chesterton Co. v. Chesterton,</i> <span class=\"citation\" data-id=\"197597\"><a href=\"/opinion/197597/aw-chesterton-v-chesterton/\"><span class=\"volume\">128</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">1</span></a></span>, 5-6 (1st Cir.1997); <i>Zimmerman,</i> 524 N.E.2d at 853; <i>Donahue,</i> 328 N.E.2d at 517; <i>Smith v. Atl. Props., Inc.,</i> 12 Mass. App.Ct. 201, <span class=\"citation\" data-id=\"2245968\"><a href=\"/opinion/2245968/smith-v-atlantic-properties-inc/\"><span class=\"volume\">422</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">798</span></a></span>, 801-02 (1981). <i>Chesterton</i> and <i>Smith</i> involved situations in which unilateral action by minority shareholders would result in dire tax consequences to the majority shareholders. <i>See A.W. Chesterton Co.,</i> 128 F.3d at 3; <i>Smith,</i> 422 N.E.2d at 800. Further, because the financial obligations were owed to the government, there was no market mechanism to determine the consequences of the action. In that sense, the minority shareholders had effective control over one aspect of corporate finances. Here, by contrast, the defendants did not inherently have effective control. Their 15% was needed only because the outside purchasers set as a condition of sale that 95% of the shareholders approve the merger. The <i>Donahue</i> rule itself involves a balancing of legitimate interests, and the scope of the duties owed may depend, in part, on context. <i>See Zimmerman,</i> 524 N.E.2d at 853 (\"[T]he <i>Donahue</i> remedy is not intended to place a strait jacket on legitimate corporate activity.\")</p>\n    </div>\n    <div class=\"num\" id=\"p39\">\n      <span class=\"num\">39</span>\n      <p class=\"indent\">The district court here found that \"[l]acking th[e] information [concerning the basis for the merger, the final terms of the merger, or the price that would be paid], Marwani certainly had a legitimate business reason for voting against the merger\" and, further, that Medical Air's refusal to provide the requested information \"left Marwani with no choice but to vote against merger.\" The district court then found that the only alternative advanced by Medical Air was for Marwani simply to vote for the Nortek merger, an alternative that totally failed to address the problems with the deal itself. This showing does not meet the plaintiff's burden.</p>\n    </div>\n    <div class=\"num\" id=\"p40\">\n      <span class=\"num\">40</span>\n      <p class=\"indent\">Medical Air argues that the district judge improperly construed the Massachusetts law governing fiduciary duty in closely held relationships by holding that Marwani Holding's own business interests could be a proper motivating factor for the vote. It argues that Marwani's vote against the merger was not motivated by legitimate business interests, saying that the vote was really motivated by the defendants' own self-interest &#8212; specifically, that Marwani wanted more of the proceeds of the merger to go to Marwan, rather than the Medical Air principals. It says that Marwani's vote against the merger was intended to pave the way for Marwan's foreclosure of Medical Air's assets, given that Medical Air's financial situation was so desperate in January 1997 that the merger was the only way to salvage the business. Medical Air relies heavily on Rahbany's testimony admitting that he did take Marwan Investment's and Marwani Holding's interests into consideration in his decision. It also relies on the statement that Marwani Holding's counsel allegedly made after the January 8 vote, complaining that Rahbany would not make enough money out of the proposed deal.</p>\n    </div>\n    <div class=\"num\" id=\"p41\">\n      <span class=\"num\">41</span>\n      <p class=\"indent\">Medical Air mischaracterizes the trial court's holding. The trial court held that Marwani Holding had a legitimate purpose in voting against the merger when it had not been provided material information about the merger and perceived a risk that the proposed merger was made of gossamer. That legitimate purpose is not negated if Marwani Holding's vote also coincided with its self-interest.</p>\n    </div>\n    <div class=\"num\" id=\"p42\">\n      <span class=\"num\">42</span>\n      <p class=\"indent\">We reject Medical Air's argument that a minority shareholder may never, under the <i>Donahue</i> rule, take its own interest into account in deciding its vote. Such an argument is both unrealistic and too biased. The SJC has observed that stockholders in a close corporation \"may not act out of avarice, expediency, or self-interest <i>in derogation of</i> their duty of loyalty to the other stockholders and to the corporation.\" <i>Blank v. Chelmsford Ob/Gyn, P.C.,</i> <span class=\"citation no-link\"><span class=\"volume\">420</span> <span class=\"reporter\">Mass.</span> <span class=\"page\">404</span></span>, <span class=\"citation no-link\"><span class=\"volume\">649</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">1102</span></span>, 1105 (1995) (emphasis added); <i>see also Donahue,</i> 328 N.E.2d at 515 (using same language). But self-interest may be a proper motive for a stockholder's actions, so long as that interest does not result in acts in derogation of the stockholder's fiduciary duty. The SJC has held that majority stockholders \"have certain rights to what has been termed `selfish ownership' in the corporation which should be balanced against the concept of their fiduciary obligation.\" <i>Wilkes,</i> 353 N.E.2d at 663. We think that principle extends, at least in part, to minority stockholders, although their interests are somewhat different in character. <i>See A.W. Chesterton Co.,</i> 128 F.3d at 7 (noting that minority stockholders may control some aspects of a corporation but not others). Admittedly, there may be tensions between the two types of interests &#8212; loyalty to the corporation and selfish ownership. Difficult cases will arise where the dividing line is not clear. This is not one of those cases.</p>\n    </div>\n    <div class=\"num\" id=\"p43\">\n      <span class=\"num\">43</span>\n      <p class=\"indent\">The district court correctly found that Marwani Holding had shown a legitimate business rationale for the vote against the merger. To begin with, Marwani Holding did lack material information about the proposed merger and Medical Air had failed to provide Marwani Holding with the requested due diligence materials. Marwani Holding also had a suspicion, reasonable in context, that the deal was based on unrealistic assumptions that would ultimately doom it, and that it served only as a distraction from the real problems facing Medical Air. This suspicion was well-founded; Medical Air's CEO admitted at trial that the fourth quarter sales estimates for 1996 provided to Nortek were above what Medical Air had ever accomplished before and far exceeded its actual fourth quarter sales results. These reasons more than suffice to show a legitimate business reason for Marwani's vote.</p>\n    </div>\n    <div class=\"num\" id=\"p44\">\n      <span class=\"num\">44</span>\n      <p class=\"indent\">Upon this showing, the burden shifted to Medical Air to show that there was \"a less harmful, reasonably practicable, alternative mode of action\" other than the vote against the merger. Medical Air has not made any such showing. The district court found that Medical Air's proposed alternative &#8212; that Marwani could have simply voted for the merger &#8212; is not a reasonable and practicable alternative, given Marwani's legitimate concerns about what form the deal would ultimately take, or whether the whole deal was simply a chimera. Its finding was compelled by the evidence.</p>\n    </div>\n    <p class=\"indent\">2. Causation</p>\n    <div class=\"num\" id=\"p45\">\n      <span class=\"num\">45</span>\n      <p class=\"indent\">The defendants argue in the alternative that, even if Marwani Holding had violated a fiduciary duty in voting against the merger, it was not the cause of the merger's failure. We agree. Nortek's CEO testified at trial (through deposition) that after Nortek saw the fourth quarter sales results, it decided that it should pay less than was offered in the original letter of intent and reopened negotiations with Medical Air. The renegotiated offer from Nortek, as expressed in the second letter of intent, provided only half what was offered in the deal before the Board at the January 8 vote. It is clear that Nortek was not willing to go through with the terms of the earlier proposed merger put before the Board that Marwani voted against. Even if Marwani Holding had voted for the proposed merger, it would have made no difference. Medical Air still would have been in the same position as it was after the January 8 vote, negotiating new terms with Nortek. No reasonable jury could find that Marwani Holding's vote was the proximate cause of the demise of the proposed Nortek merger.</p>\n    </div>\n    <p class=\"indent\">\n      <i>C. Other Claims</i>\n    </p>\n    <div class=\"num\" id=\"p46\">\n      <span class=\"num\">46</span>\n      <p class=\"indent\">The plaintiff's other claims are similarly lacking in merit. The remaining questions decided by the district court in the bench trial were: a claim against MFH for breach of the consulting agreement; a breach of the implied covenant of good faith and fair dealing against Marwani Holding based on its vote against the Nortek merger; and tortious interference with contractual relations against Rahbany, MFH, and Marwani Holding for their actions with regard to the Nortek merger.<a class=\"footnote\" href=\"#fn5\" id=\"fn5_ref\">5</a> The latter two claims must fail, for the same reasons that the fiduciary duty claim against Marwan Holding fails. Neither Rahbany nor MFH took any actions with regards to the Nortek deal that were separate from the actions taken by Marwan Holding, discussed above. Medical Air has not presented any evidence to indicate that these actions, rather than Medical Air's inability to meet fourth quarter sales projections, caused the proposed merger before the Board on January 8 to fail. Without causation, there can be no claim for tortious interference, <i>see United Truck Leasing Corp. v. Geltman,</i> <span class=\"citation\" data-id=\"2090012\"><a href=\"/opinion/2090012/united-truck-leasing-corp-v-geltman/\"><span class=\"volume\">406</span> <span class=\"reporter\">Mass.</span> <span class=\"page\">811</span></a></span>, <span class=\"citation\" data-id=\"2090012\"><a href=\"/opinion/2090012/united-truck-leasing-corp-v-geltman/\"><span class=\"volume\">551</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">20</span></a></span>, 21 (1990), or for a breach of the implied covenant of good faith and fair dealing, <i>see Druker v. Roland Wm. Jutras Assocs.,</i> <span class=\"citation\" data-id=\"2009105\"><a href=\"/opinion/2009105/druker-v-roland-wm-jutras-associates-inc/\"><span class=\"volume\">370</span> <span class=\"reporter\">Mass.</span> <span class=\"page\">383</span></a></span>, <span class=\"citation\" data-id=\"2009105\"><a href=\"/opinion/2009105/druker-v-roland-wm-jutras-associates-inc/\"><span class=\"volume\">348</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">763</span></a></span>, 765 (1976) (\"[I]n every contract there is an implied covenant [of good faith and fair dealing] that neither party shall do anything which will have the effect of destroying or injuring the right of the other party to receive the fruits of the contract....\") (quoting <i>Uproar Co. v. Nat'l Broad. Co.,</i> <span class=\"citation\" data-id=\"1475264\"><a href=\"/opinion/1475264/uproar-co-v-national-broadcasting-co/\"><span class=\"volume\">81</span> <span class=\"reporter\">F.2d</span> <span class=\"page\">373</span></a></span>, 377 (1st Cir.1936)); <i>MacGillivary v. W. Dana Bartlett Ins. Agency of Lexington, Inc.,</i> 14 Mass.App.Ct. 52, <span class=\"citation\" data-id=\"2062849\"><a href=\"/opinion/2062849/macgillivary-v-w-dana-bartlett-ins-agency/\"><span class=\"volume\">436</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">964</span></a></span>, 967 (1982).</p>\n    </div>\n    <div class=\"num\" id=\"p47\">\n      <span class=\"num\">47</span>\n      <p class=\"indent\">That leaves only Medical Air's claim that MFH violated its contractual obligations under the consulting agreement. The district court outlined the alleged claim well in its opinion. The consulting agreement required MFH to provide \"financial and strategic corporate planning services\" to Medical Air \"including, by way of example: (i) assisting [Medical Air] in attracting a new senior lender; (ii) evaluating and helping source transactions such as acquisitions, joint ventures and public offerings; and (iii) assisting [Medical Air] in developing financial and operating reporting systems.\" Medical Air's CEO, Stephen Hague, testified that MFH did nothing to help attract a new lender or to develop financial and operating reporting systems. However, Hague also testified that he met on a monthly basis for a few hours with the consultant provided by MFH, as well as speaking with him on the phone for a few hours each month. During these meetings, the consultant reviewed the operation of the company and proposals for the company. According to Hague, the consultant encouraged Medical Air to expand its sales force rapidly; assisted in putting together an expansion plan; recommended and outlined the creation of a business advisory board; and investigated at least one possible acquisition. The consultant also occasionally interviewed or spoke with sales representatives. In addition, Medical Air did effect changes in its accounting procedures during this time period; the consultant was copied on the relevant documents, but the record is not clear as to what his level of participation was.</p>\n    </div>\n    <div class=\"num\" id=\"p48\">\n      <span class=\"num\">48</span>\n      <p class=\"indent\">In August 1996, the consultant who had been working with Medical Air ceased to work for MFH. In September, Medical Air stopped paying the $4,000 per month consultancy fee. In October 1996, Medical Air met with a new individual that MFH had appointed to replace the previous consultant, but that was the last service provided under the consultancy agreement. At this point, Medical Air was already in default of its obligations under the Investment and Stockholders Agreement.<a class=\"footnote\" href=\"#fn6\" id=\"fn6_ref\">6</a></p>\n    </div>\n    <div class=\"num\" id=\"p49\">\n      <span class=\"num\">49</span>\n      <p class=\"indent\">Based on the information provided by Medical Air's CEO, we doubt that Medical Air has presented enough evidence on this claim for it to go to a jury. It is undisputed that the MFH consultant worked with Medical Air throughout the relevant time period and provided input on the business's development. As the district court noted, the fact that the MFH consultant did not achieve all of the goals laid out \"by way of example\" in the consulting agreement did not constitute breach, given how quickly the entire relationship disintegrated and the agreement's lack of any time frame for achieving these goals.</p>\n    </div>\n    <div class=\"num\" id=\"p50\">\n      <span class=\"num\">50</span>\n      <p class=\"indent\">Regardless of the strength of the claim, however, the claim is no longer Medical Air's to make. Marwan Investment purchased all the assets of Medical Air at the foreclosure sale in November 1998. The description of assets included \"all rights, claims, counterclaims, cross-claims, demands, recoveries and defenses in connection with or asserted or which may be asserted by Medical Air in that certain litigation styled <i>Medical Air Technology Corporation v. Marwan Investment</i>... pending in the United States District Court for the District of Massachusetts.\" Under Massachusetts law, claims for breach of contract are generally assignable.<a class=\"footnote\" href=\"#fn7\" id=\"fn7_ref\">7</a> <i>Raymer v. Bay State Nat'l Bank,</i> <span class=\"citation\" data-id=\"2074976\"><a href=\"/opinion/2074976/raymer-v-bay-state-national-bank/\"><span class=\"volume\">384</span> <span class=\"reporter\">Mass.</span> <span class=\"page\">310</span></a></span>, <span class=\"citation\" data-id=\"2074976\"><a href=\"/opinion/2074976/raymer-v-bay-state-national-bank/\"><span class=\"volume\">424</span> <span class=\"reporter\">N.E.2d</span> <span class=\"page\">515</span></a></span>, 518 (1981); <i>see also SAPC, Inc. v. Lotus Dev. Corp.,</i> <span class=\"citation\" data-id=\"553167\"><a href=\"/opinion/553167/sapc-inc-v-lotus-development-corporation/\"><span class=\"volume\">921</span> <span class=\"reporter\">F.2d</span> <span class=\"page\">360</span></a></span> (1st Cir.1990). Although there may be cases in which public policy concerns merit the creation of an exception to that rule when the claim has been involuntarily assigned through a foreclosure sale, this is not such a case. If the claim for breach of the consulting agreement constituted a defense to the defendants' claim of default, or if it would have saved Medical Air as an ongoing concern, than Medical Air should have raised this as a defense to the defendants' summary judgment motion on the default claim. Medical Air did not do so, nor did it raise any contemporaneous objection to the inclusion of its rights in this matter in the assets foreclosure sale.</p>\n    </div>\n    <p class=\"indent\">\n      <i>Conclusion</i>\n    </p>\n    <div class=\"num\" id=\"p51\">\n      <span class=\"num\">51</span>\n      <p class=\"indent\">The district court's decision is <i>affirmed.</i> No costs are awarded.</p>\n    </div>\n    <div class=\"footnotes\">\n      <div class=\"footnote\">\n        <p>Notes:</p>\n      </div>\n      <div class=\"footnote\" id=\"fn1\">\n        <a class=\"footnote\" href=\"#fn1_ref\">1</a>\n        <p> Rahbany testified that one of the reasons justifying his suspicions of the deal was Medical Air's failure to certify the purchase price, although he did not voice that suspicion to Medical Air at the time</p>\n      </div>\n      <div class=\"footnote\" id=\"fn2\">\n        <a class=\"footnote\" href=\"#fn2_ref\">2</a>\n        <p> The court initially noted, \"If I understand correctly, regardless of whether you think &#8212; you talk in terms of integrated documents or anything else, it is very, very clear that the plaintiff waived jury; is that right?\" Medical Air's counsel responded by arguing that the only waiver was in the Security Agreement, and it applied only to Marwan Investment. The judge then said:</p>\n        <p class=\"indent\">But you did waive. With respect to this case, you waived jury.</p>\n        <p class=\"indent\">...</p>\n        <p class=\"indent\">Do you know of any precedent where you can waive with respect to one defendant and not with respect to another? I have never tried a case like that. I would not know how to preside.... I am just talking about within the cast, the traditional cast, of a transaction, one plaintiff, four people, some actual signatory, some by inference, perhaps, but the plaintiff says, I waive jury. Doesn't that count for everything?</p>\n      </div>\n      <div class=\"footnote\" id=\"fn3\">\n        <a class=\"footnote\" href=\"#fn3_ref\">3</a>\n        <p> The circuits are currently split on the question of which party bears the burden of proof as to whether a contractual jury trial waiver was knowing and voluntary<i>See Pierce v. Atchison Topeka &amp; Santa Fe Ry. Co.,</i> <span class=\"citation\" data-id=\"739091\"><a href=\"/opinion/739091/eugene-pierce-v-the-atchison-topeka-and-santa-fe-railway-co-dba-santa/\"><span class=\"volume\">110</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">431</span></a></span>, 435 n. 4 (7th Cir.1997) (collecting cases); <i>Hulsey v. West,</i> <span class=\"citation\" data-id=\"584311\"><a href=\"/opinion/584311/larry-o-hulsey-v-lee-r-west-district-judge-united-states-district/\"><span class=\"volume\">966</span> <span class=\"reporter\">F.2d</span> <span class=\"page\">579</span></a></span>, 581 (10th Cir.1992). We have not yet ruled on this point, although a district court within this circuit has held that the party seeking to enforce the waiver bears the burden. <i>See Luis Acosta, Inc. v. Citibank, N.A.,</i> <span class=\"citation\" data-id=\"1461480\"><a href=\"/opinion/1461480/luis-acosta-inc-v-citibank-na/\"><span class=\"volume\">920</span> <span class=\"reporter\">F. Supp.</span> <span class=\"page\">15</span></a></span>, 18 (D.P.R. 1996). In the analogous situation of a release of claims against an employer, we have held that the party seeking to enforce the release bears the burden of proof. <i>See Melanson v. Browning-Ferris Indus.,</i> <span class=\"citation\" data-id=\"199838\"><a href=\"/opinion/199838/melanson-v-browning-ferris/\"><span class=\"volume\">281</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">272</span></a></span>, 276 (1st Cir.2002). We need not resolve the issue here.</p>\n      </div>\n      <div class=\"footnote\" id=\"fn4\">\n        <a class=\"footnote\" href=\"#fn4_ref\">4</a>\n        <p> In analogous situations we have looked to the \"totality of the circumstances,\" including factors such as the waiving party's education and business experience, the respective roles of the parties in determining the terms of the waiver, the clarity of the agreement, the amount of time the waiving party had to consider the waiver, whether the waiving party was represented by counsel, and the consideration offered for the waiver, to determine if the waiver was knowing and voluntary<i>Melanson,</i> 281 F.3d at 276 &amp; n. 4 (waiver of Title VII rights through release of claims against employer); <i>Smart v. Gillette Co. Long-Term Disability Plan,</i> <span class=\"citation\" data-id=\"196424\"><a href=\"/opinion/196424/smart-v-the-gillette-company/\"><span class=\"volume\">70</span> <span class=\"reporter\">F.3d</span> <span class=\"page\">173</span></a></span>, 181-82 (1st Cir.1995) (waiver of ERISA pension benefits).</p>\n      </div>\n      <div class=\"footnote\" id=\"fn5\">\n        <a class=\"footnote\" href=\"#fn5_ref\">5</a>\n        <p> Medical Air did not appeal the merits of the district court's rulings on these claims. We consider the question only for the purpose of Medical Air's appeal of the denial of a jury trial on all of its claims against MFH, Rahbany and Marwani Holding</p>\n      </div>\n      <div class=\"footnote\" id=\"fn6\">\n        <a class=\"footnote\" href=\"#fn6_ref\">6</a>\n        <p> Medical Air did not argue that MFH's breach was based on the failure to provide ongoing consultancy services after September 1996</p>\n      </div>\n      <div class=\"footnote\" id=\"fn7\">\n        <a class=\"footnote\" href=\"#fn7_ref\">7</a>\n        <p> The defendants have argued that all of Medical Air's claims are assignable, whether or not they sound in contract. We need not decide this point, as we have disposed of Medical Air's other claims on other grounds</p>\n      </div>\n    </div>\n    ",
  "extracted_by_ocr": false,
  "opinions_cited": [
    "http://www.courtlistener.com/api/rest/v3/opinions/20718/",
    "http://www.courtlistener.com/api/rest/v3/opinions/102830/",
    "http://www.courtlistener.com/api/rest/v3/opinions/106535/",
    "http://www.courtlistener.com/api/rest/v3/opinions/118475/",
    "http://www.courtlistener.com/api/rest/v3/opinions/196424/",
    "http://www.courtlistener.com/api/rest/v3/opinions/196436/",
    "http://www.courtlistener.com/api/rest/v3/opinions/197597/",
    "http://www.courtlistener.com/api/rest/v3/opinions/199838/",
    "http://www.courtlistener.com/api/rest/v3/opinions/200173/",
    "http://www.courtlistener.com/api/rest/v3/opinions/394161/",
    "http://www.courtlistener.com/api/rest/v3/opinions/449501/",
    "http://www.courtlistener.com/api/rest/v3/opinions/512976/",
    "http://www.courtlistener.com/api/rest/v3/opinions/542054/",
    "http://www.courtlistener.com/api/rest/v3/opinions/553167/",
    "http://www.courtlistener.com/api/rest/v3/opinions/584311/",
    "http://www.courtlistener.com/api/rest/v3/opinions/592214/",
    "http://www.courtlistener.com/api/rest/v3/opinions/726747/",
    "http://www.courtlistener.com/api/rest/v3/opinions/739091/",
    "http://www.courtlistener.com/api/rest/v3/opinions/768061/",
    "http://www.courtlistener.com/api/rest/v3/opinions/1461480/",
    "http://www.courtlistener.com/api/rest/v3/opinions/1475264/",
    "http://www.courtlistener.com/api/rest/v3/opinions/2009105/",
    "http://www.courtlistener.com/api/rest/v3/opinions/2059671/",
    "http://www.courtlistener.com/api/rest/v3/opinions/2062849/",
    "http://www.courtlistener.com/api/rest/v3/opinions/2063601/",
    "http://www.courtlistener.com/api/rest/v3/opinions/2073798/",
    "http://www.courtlistener.com/api/rest/v3/opinions/2074976/",
    "http://www.courtlistener.com/api/rest/v3/opinions/2090012/",
    "http://www.courtlistener.com/api/rest/v3/opinions/2219112/",
    "http://www.courtlistener.com/api/rest/v3/opinions/2245968/"
  ]
}